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CHECKLISTS AMD ILLUSTRATIVE FINANCIAL STATEMENTS 
FOR HEALTH CARE PROVIDERS
The checklists and illustrative financial statements in this
publication have been developed by the staff of the Technical 
Information Division of the AICPA as nonauthoritative practice aids. 
Readers should be aware of the following:
• The checklists and illustrative financial statements and 
reports are "tools" and do not represent official positions or 
pronouncements of the AICPA.
• The checklists and illustrative financial statements and 
reports have been updated through FASB Statement No. 109, 
FASB Interpretation No. 39, FASB Technical Bulletin No. 90-1, 
AICPA Statement of Position No. 92-3, AICPA Statement on 
Auditing Standards No. 71, AICPA Statement on Standards for 
Accounting and Review Services No. 7, and AICPA Audit and 
Accounting Guide, Audits of Providers of Health Care Services 
(Second Edition 1991). The checklists and illustrative 
financial statements and reports should be modified, as 
appropriate, for subsequent pronouncements. In determining 
the applicability of a pronouncement, its effective date 
should be considered.
• The checklists and illustrative financial statements should be 
used by, or under the supervision of, persons having adequate 
technical training and proficiency in the application of 
generally accepted accounting principles, generally accepted 
auditing standards, and statements on standards for accounting 
and review services.
• The checklists and illustrative financial statements and 
reports do not represent minimum requirements and do not 
purport to be all-inclusive. The referenced standards should 
be reviewed if clarification is desired as to whether the 
disclosure indicated is required or suggested, and to what 
extent the disclosure is relevant to the statements and report 
being issued.
Users of the checklists and illustrative financial statements and 
reports are urged to refer directly to the applicable authoritative 
pronouncements when possible. If you have a question, please call the 
AICPA Technical Hotline (see back cover).
The author wishes to acknowledge the assistance of his colleagues, 
Annette J. Schumacher, CPA, Michael A. Tursi, CPA, and David J. Perlman, 
CPA, who served as consultants on this project, and to the members of 
the AICPA Health Care Committee for their comments and suggestions.
Susan L. Menelaides 
Director
Technical Information
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INTRODUCTION
Health care costs as well as the number of people requiring health care 
services has consistently risen. As a result, many health care 
providers are relying more heavily on debt financing to meet capital 
needs creating a greater need for accountability to creditors and 
investors.
Health care entities may be classified by sponsorship or legal structure 
within three broad categories: voluntary (not-for-profit),
governmental, and investor- (or operator-) owned.
Voluntary (Not-For-Profit): an entity that operates under the
direction of governing boards. Usually exempt from federal and 
state income taxes if operated exclusively for religious, 
charitable, scientific or educational purposes, the entity may be 
further classified as community-based, religious-affiliated or 
university-sponsored.
Governmental: Often called public health care entities, the entity 
is owned and operated by federal, state, city or county governments 
or other political subdivisions.
Investor- (or operator-) Owned: a health care entity that operates 
as a stock corporation, partnership or sole proprietorship.
Health care entities include, but are not limited to:
o Clinics, medical group practices, individual practitioners and 
practice associations, and other ambulatory care organizations
o Continuing care retirement communities (CCRCs)
o Health maintenance organizations and similar prepaid health 
care plans
o Home health agencies
o Hospitals
o Nursing homes that provide skilled, intermediate, and less
intensive levels of health care
o Parent, holding and other organizations that primarily plan, 
organize and oversee health care services
Legislation and Regulation
Significant aspects of health care entity operations are affected by 
government legislation and regulation with many states adopting laws 
governing the granting of licenses as well as scope of services to be 
rendered. In addition, many independent organizations and governmental
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agencies, including Medicare and Medicaid, evaluate programs and 
services of health care entities to determine compliance with set 
standards.
Basic Financial Statements
The basic financial statements of not-for-profit and governmental health 
care entities generally consist of a balance sheet, statement of 
revenues and expenses of general funds, statement of changes in fund 
balances, and a statement of cash flows of general funds (and restricted 
funds of governmental entities). The basic financial statements of 
investor-owned health care entities are similar to those of other 
investor-owned entities. Aggregated (combined fund) and disaggregated 
(layered fund) balance sheets are acceptable alternatives to reporting 
financial position of not-for-profit health care entities and 
governmental hospitals.
Structure of the Checklist
In July 1990, the AICPA published a new audit and accounting guide 
entitled Audits of Providers of Health Care Services (the Guide) . The 
recommendations contained in the Guide and this checklist apply to the 
separate financial statements of health care entities that are either 
(a) investor-owned, (b) not-for-profit or (c) state or local government- 
owned users of enterprise fund accounting and reporting. Financial 
statements of a state or local governmental health care entity are 
subject to statements and interpretations of the Governmental Accounting 
Standards Board (GASB) as well as AICPA and Financial Accounting 
Standards Board (FASB) pronouncements as specified by GASB statements 
and interpretations. This checklist presents fund accounting guidance 
first. Any modifications needed to reflect non-fund accounting are 
presented in brackets immediately after the related fund accounting 
guidance.
Not-for-profit health care providers that receive federal financial 
assistance may be required to have an audit conducted in accordance with 
Office of Management and Budget (OMB) Circular A-133, Audits of 
Institutions of Higher Education and Other Nonprofit Institutions. 
Appendix A is a supplemental checklist for auditor's reports for audits 
performed under A-133.
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Checklists--General
Many Auditors and accountants find it helpful to use checklists as 
practice aids in preparing financial statements and reports. Some 
firms have developed their own checklists for internal use, and may 
also have specialized checklists to meet the needs of their 
practices, such as checklists for clients in particular industries 
or clients that report to the SEC. Some state CPA societies have 
developed checklists as practice aids that may be available to 
other practitioners as well as to their own members. Some 
commercial publishers also include checklists in certain of their 
publications. However, authoritative literature does not require 
the use of such checklists, nor does it prescribe their format or 
content, which may vary.
Checklists typically consist of a number of brief questions or 
statements that are accompanied by references to Statements on 
Auditing Standards, Statements on Standards for Accounting and 
Review Services, Statements of Financial Accounting Standards, 
Accounting Principles Board Opinions and Accounting Research 
Bulletins. Some checklists also include references to FASB 
Interpretations, Statements of Position and Industry Audit Guides. 
The extent of detail included in checklists varies with the 
judgment of the preparers on how extensively to refer to and 
highlight authoritative literature without developing a checklist 
that is too long and unwieldy. Accordingly, checklists may serve 
as convenient memory aids but cannot be used as a substitute for 
direct references to the authoritative literature.
Checklists usually provide for checking off or initialling each 
question or point to show that it has been considered. The format 
used herein is a typical one; it provides for "yes," "no," and "not 
applicable" answers and presumes that remarks would be prepared on 
separate cross-referenced memorandums. Some preparers, however, 
prefer to include space for remarks in the body of the checklist 
while others prefer alternative checklist formats. For example, a 
checklist format may provide for the following set of answers: "not 
applicable," "not material, " "in statements," and "in notes" (with 
provisions for indicating a cross reference to the specific 
statement caption or note). Another format may provide for only 
two answers, "disclosed" and "not applicable." Firms and 
practitioners who develop their own checklists should adopt formats 
that suit their needs and preferences.
Disclosure checklists are generally accompanied by caveats that 
include all of the following points:
• Use of the checklists requires the exercise of individual 
professional judgment and may likely require some 
modification based on the circumstances of individual 
engagements.
• The checklists are not all-inclusive and are not intended
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to present minimum requirements.
• Users need to modify the checklists for any 
pronouncements issued subsequent to those mentioned in 
the checklist.
If widespread circulation is expected, the preparers also generally 
stress the nonauthoritative or unofficial status of the checklists 
and disclaim responsibility for the way they may be used.
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Explanation of References
AAG or Guide = AICPA Audit and Accounting Guide. Audits of 
Providers of Health Care Services. Second 
Edition
AC Section in FASB Accounting Standards Current 
Text
APB AICPA Accounting Principles Board Opinion
AR AICPA Professional Standards (vol. 2)
ARB AICPA Accounting Research Bulletin
AU AICPA Professional Standards (vol. 1)
FASBI FASB Interpretation
FASCON FASB Statement of Financial Accounting
Concepts
SAS AICPA Statement on Auditing Standards
SFAS FASB Statement of Financial Accounting
Standards
SOP AICPA Statement of Position
SSARS AICPA Statement on Standards for Accounting 
and Review Services
TB FASB Technical Bulletin
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CHECKLIST QUESTIONNAIRE
This checklist has been developed by the staff of the Technical 
Information Division of the AICPA as a nonauthoritative practice 
aid.
Yes No
I. ACCOUNTING PRINCIPLES OF MEASUREMENT AND 
DISCLOSURE
A. Fund Accounting
1. General funds
a. For classified balance sheets, are assets 
and liabilities classified as current and 
noncurrent, with totals presented for 
current assets and current liabilities?
[AAG, par. 3.04; ARB 43, Ch. 3A
(AC B05.103-.109); SFAS 6, par. 15
(AC B05.118); TB 79-3 (AC B05.501-.503)] _________
b. Are the following limited-use assets 
included in the general funds?
(1).  Board-designated assets. _____  ___
(2).  Proceeds of debt issues. _____  ___
(3).  Funds deposited with a trustee and
limited to use in accordance with
requirements of an indenture or similar
agreement. _________
(4).  Other assets whose use is limited by an
arrangement between the provider and an 
outside party other than a donor or 
grantor (such as assets set aside to 
meet depreciation funding requirements 
or self-insurance funding agreements).
[AAG, par. 3.05] _________
c. Are agency funds (assets owned by others
under agency relationships such as 
patients or physicians) and their related 
liabilities reported in the general funds? _____  ___
d. Are transactions involving receipt and 
disbursement of agency funds excluded from
6
N/A
Yes No N/A
the results of operations? 
[AAG, par. 3.06]
e. Is property and equipment used for general 
operations (and related liabilities) 
reported in the general funds?
f. Is property and equipment not used for 
general operations (such as property 
acquired for future expansion or 
investment purposes) presented as a 
separate item in the general funds?
[AAG, pars. 3.07 and 8.06]
2. Donor-restricted funds
a. Is donor-restricted property and equipment 
(such as real estate investments of 
endowment funds) reported in the 
appropriate donor-restricted fund?
[AAG, pars. 3.07 and 8.07]
b. Are resources restricted by donors for 
additions to property and equipment 
reported in restricted plant replacement 
and expansion funds?
c. Are plant replacement and expansion funds 
reported in the statement of changes in 
fund balances when expenditures are 
incurred for the purpose intended by the 
donor?
[AAG, par. 3.10]
d. Do "term endowment funds" include 
resources whose principal may be expended 
after the donor-imposed time or after 
other restrictions are satisfied?
e. Is all pertinent information about term 
endowment funds (such as term and 
purposes) disclosed in the notes?
f. Are term endowment funds available for 
unrestricted purposes reported in the 
statement of revenues and expenses?
g. Are term endowment funds that became
7
Yes No N/A
available, but are further restricted 
under the term endowment provisions, shown 
as a reclassification to the appropriate 
donor-restricted fund in the statement of 
changes in fund balances?
[AAG, par. 3.11] _____
h. Do endowment funds include resources whose 
principal may not be expended?
[AAG, par. 3.13] _____
B. Donated Funds Held in Trust
1. If donated resources are held in a trust (by 
an independent trustee), of which the 
provider is not the remainderman:
a. Are they excluded from the balance sheet? _____
b. Is their existence disclosed?
[AAG, par. 3.14] _____
2. Has disclosure been considered of the right
to future income and the principal held in 
trust? _____
3. If the provider received a distribution, 
was it reported in accordance with the terms 
of the trust or agreement with the trustee? 
[AAG, par. 3.15]
4. If the provider is the remainderman, were 
the donated funds reported as assets 
(depending on the terms of the trust 
document)?
[AAG, par. 3.16]
C. Financial Statements
1. For not-for-profit and governmental
providers, do the basic financial statements 
include:
a. A balance sheet?
b. A statement of revenues and expenses of 
general funds?
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Yes No N/A
c. A statement of changes in fund balances? _____
d. A statement of cash flows of general funds
(and restricted funds of governmental 
entities)? _____
2. For investor-owned providers, are the basic 
financial statements similar to those of 
other investor-owned providers?
[AAG, par. 3.24] _____
II. CASH AND CASH EQUIVALENTS
A. General
1. Is restricted cash appropriately segregated 
from cash available for current operations?
[ARB 43, Ch. 3A, par. 6 (AC B05.107)] _____
2. Are restrictions on cash (such as for plant 
acquisition, debt reduction or working 
capital maintenance) appropriately 
disclosed?
[SFAS 5, pars. 18-19 (AC C59.120)] _____
B. Personal Fund Accounts
1. Are personal funds of patients, residents 
and others under an agency arrangement, 
reported as assets and corresponding 
liabilities in the balance sheet? _____
2. Is the amount of personal funds reported as 
assets disclosed parenthetically on the 
balance sheet or in the notes?
[AAG, par. 5.06]
C. Cash Equivalents
1. Is the policy for determining cash 
equivalents disclosed?
[SFAS 95, par. 10 (AC C25.108)]
III. INVESTMENTS
A. General
1. Are investments of general funds
9
Yes No N/A
reported as current or noncurrent assets in 
conformity with GAAP?
[AAG, par. 6.01]
2. Are the appropriate disclosures made for 
investments in common stock accounted for by 
the equity method?
[APB 18, par. 20 (AC I82.110)]
3. Are other securities (such as real estate) 
reported at amortized cost, or at lower of 
cost or market if an impairment in value is 
deemed to be other than temporary?
[AAG, par. 6.02c]
B. Marketable Equity Securities
1. For marketable equity securities do 
disclosures include:
a. For each balance sheet presented, 
aggregate cost and market value (each 
segregated between current and non-current 
portfolios when a classified balance sheet 
is presented) with identification as to 
which is the carrying amount?
b. For the latest balance sheet presented, 
gross unrealized gains and gross 
unrealized losses (each segregated between 
current and noncurrent portfolios when 
applicable)?
[SFAS 12, pars. 12b and 16a (AC I89.106b 
and .110a)]
c. For each period for which a statement of 
revenues and expenses (statement of 
operations) is presented:
(1).  Net realized gain or loss included in
the statement?
(2).  Basis on which cost was determined in
calculating realized gain or loss (such 
as average cost or FIFO)?
[AAG, par. 6.09; SFAS 12, pars. 12 and 
16 (AC I89.106 and .110)]
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Yes No N/A
2. Are significant net realized and net 
unrealized gains and losses that arose after 
the latest balance sheet date but before 
issuance of the financial statements 
disclosed?
[AAG, par. 6.10; SAS 1, sec. 560, pars. 5 
and 7 (AU 560.05 and .07); SFAS 12, pars. 13 
and 17 (AC I89.107 and .111); FASBI 11, 
pars. 3-4 (AC I89.115-.116); FASBI 13, pars.
5-7 (AC I89.120-.122)] _____
3. Are losses due to a change in classification 
of a marketable equity security between 
current and noncurrent reported in the 
statement of revenues and expenses?
[AAG, par. 6.12; SFAS 12, par. 10 (I89.104)] _____
4. For a portfolio included in current assets 
in the general funds, are changes in the 
valuation allowance disclosed and reported
in the statement of revenues and expenses? _____
5. For a portfolio included in noncurrent 
assets, or assets in unclassified balance 
sheets or restricted funds, are changes in 
the valuation allowance disclosed and 
reported in the respective statement of 
changes in fund balances or equity?
[AAG, par. 6.12; SFAS 12, par. 11 (AC
I89.105)] _____
6. Are realized gains or losses on the sale of 
investments of endowment funds added to or 
deducted from the funds’ principal (unless 
such amounts are legally available for other 
use or chargeable to other funds)?
[AAG, par. 6.13] _____
7. Are income and net realized gains or losses 
on investments of restricted funds (other 
than endowment funds) added to or deducted 
from the respective fund balance (unless 
such amounts were legally available for
other use or chargeable to other funds)? _____
a. If such amounts are legally available for 
unrestricted purposes, are they reported 
in the statement of revenues and expenses? _____
11
Yes No N/A
b. Are gains or losses on investment trading 
between general and restricted funds and 
between various categories of restricted 
funds (such as between endowment and plant 
expansion funds) separately disclosed in 
the financial statements?
[AAG, par. 6.14]
IV. RECEIVABLES
1. Are charity care revenue and receivables 
excluded from the financial statements?
[AAG, par. 7.02]
2. Are differences between the estimates 
originally reported and final settlements:
a. Included in the statement of revenues and 
expenses (statement of operations) in the 
period the settlements are made?
b. Reported in the current period unless they 
meet the criteria for prior period 
adjustments?
[AAG, par. 7.09; SFAS 16 (AC A35)]
3. Are advances from third-party payers 
reported as a liability (unless the right of 
setoff against a related receivable
applies)?
[AAG, par. 7.11]
4. Are deposits received from individuals 
reported as a liability (to the extent that 
a right of setoff does not exist)?
[AAG, par. 7.12]
5. Are receivables (less an allowance for 
uncollectibles, discounts, and contractual 
adjustments) reported as current assets in 
the general funds?
a. If the terms of payment have been extended 
beyond one year from the balance sheet 
date, has that portion been classified as 
noncurrent?
12
Yes No N/A
b. Has consideration been given to
segregating amounts due from third-party 
payors for retroactive adjustments of 
items such as final settlements or 
appeals?
AAG, par. 7.16
6. If financial statements present assets and 
liabilities by fund groups:
a. Are interfund receivables or payables 
reported separately by fund?
b. In a classified balance sheet, are they 
reported as current or noncurrent in 
general funds?
7. If financial statements do not present 
assets and liabilities by fund groups, have 
interfund receivables and payables been 
eliminated?
8. Have circumstances and terms of formal 
interfund borrowing agreements been 
disclosed?
AAG, par. 7.17
9. Are pledges reported in the period in which 
they were made?
a. Are pledges reported net of an allowance 
for uncollectible amounts?
b. Are unrestricted pledges reported in the 
statement of revenues and expenses 
statement of operation?
c. If a portion of a pledge is to be applied 
during some future period, was that part 
reported in the general fund in the period 
in which it was received as deferred 
revenue or, if restricted, as an addition 
to donor-restricted funds?
d. If pledges were restricted in any other 
way, are they reported as additions to 
donor-restricted funds?
AAG, par. 7.18
13
Yes No N/A
10. Are all receivables reported net of any 
related allowance for uncollectible amounts 
with appropriate disclosure?
[AAG, par. 7.19; APB 12, par. 3 
(AC V18.102)]
11. Are accounts and notes receivable from 
officers, employees, and affiliated 
organizations shown separately with 
appropriate disclosures?
[ARB 43, Ch. 1A, par. 5 (AC R36.105)]
V. PROPERTY AND EQUIPMENT, SUPPLIES AND OTHER 
ASSETS
1. Has property acquired for future expansion 
or investment been presented separately in 
the general funds?
AAG, par. 8.06
2. Has property and equipment of 
donor-restricted funds (such as property 
received as a donation to endowment funds) 
been reported in the appropriate 
donor-restricted fund?
AAG, par. 8.07
3. Are donor or legal restrictions on the 
proceeds from the disposition of property 
and equipment disclosed?
AAG, par. 8.06
4. For depreciable assets, do the financial 
statements or notes disclose:
a. Depreciation expense for each period?
b. Balances of major classes of depreciable 
assets by nature or function?
c. Accumulated depreciation, either by major 
classes of assets or in total?
d. The method or methods used in computing 
depreciation with respect to major classes 
of depreciable assets?
[APB 12, par. 5 (AC D40.105)]
14
Yes No N/A
5. Are the costs of intangible assets acquired 
from other entities recorded as assets?
6. Are the costs of developing, maintaining or 
restoring intangible assets which are not 
specifically identifiable, have
indeterminate lives, or are inherent in a 
continuing business and related to the 
entity as a whole, expensed when incurred?
[APB 17, par. 24 (AC 160.105)] _____
7. Are issue costs of debt reported as deferred 
charges?
[APB 21, par. 16 (AC I69.109)] _____
8. Do disclosures include the method and period 
of amortization of intangible assets?
[APB 22, par. 13 (AC A10.106)] _____
9. In a classified balance sheet:
a. Have deferred tax assets been classified 
as current or noncurrent based on the 
classification of the related asset or 
liability for financial reporting?
[SFAS 109, par. 41 (AC I27.140)] _____
b. Have deferred tax assets not related to an 
asset or liability for financial reporting 
(including those related to carryforwards) 
been classified according to the expected 
reversal date of the temporary difference?
[SFAS 109, pars. 41 and 288p (AC I27.140)] _____
c. Has the valuation allowance for a 
particular tax jurisdiction been allocated 
between current and noncurrent deferred 
tax asssets for that tax jurisdiction on a 
pro rata basis?
[SFAS 109, par. 41 (AC I27.140)] _____
d. Have the following items been offset and 
presented as a single amount for a 
particular tax-paying component and within 
a particular tax-paying jurisdiction:
(1). All current deferred tax liabilities and 
assets?
15
Yes No N/A
(2). All noncurrent deferred tax liabilities 
and assets?
[SFAS 109, par. 42 (AC I27.141)]
10. Have the totals of a) all deferred tax 
assets and b) the related valuation 
allowance recognized in the balance sheet 
been disclosed?
[SFAS 109, par. 43 (AC I27.142)]
11. Has an asset (prepaid pension cost) been 
recognized if net periodic pension cost is 
less than amounts the employer has 
contributed to the plan?
[SFAS 87, par. 35 (P16.129)]
12. If an additional minimum pension liability 
has been recognized, has an equal amount 
been recognized as an intangible asset, 
provided that the asset recognized does not 
exceed the amount of unrecognized prior 
service cost?
[SFAS 87, pars. 36-37 (AC P16.130-.131)]
13. Is the financial statement presentation of 
supplies and other assets similar to that of 
other business organizations?
AAG, par. 8.08
VI. CURRENT LIABILITIES, NOTES PAYABLE AND OTHER 
DEBT
A. Current Liabilities
1. Do current liabilities include:
a. Obligations for items that have entered 
the operating cycle?
b. Collections received in advance of the 
performance of services?
c. Debts that arise from operations directly 
related to the operating cycle?
d. Other liabilities whose regular and 
ordinary liquidation is likely to occur 
within a relatively short time period?
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e. Obligations that, by their terms, are due 
on demand or will be due within one year 
(or operating cycle, if longer) from the 
balance sheet date, even though
liquidation may not be expected within 
that period?
[ARB 43, Ch. 3A, pars. 7-8 (AC 
B05.108-.109); SFAS 78, par. 5 (AC 
B05.109A)]
2. Do current liabilities exclude short-term 
obligations that the provider intends to 
refinance on a long-term basis, provided the 
provider has demonstrated the ability to 
consummate the long-term financing?
[SFAS 6, pars. 8-14 (AC B05.112-.116);
FASBI 8 (AC B05.117 and .138-.139)]
B. Notes Payable and Other Debt
1. Is there adequate disclosure of interest 
rates, maturities, and other terms and 
conditions provided in loan agreements and 
bond indentures (such as assets pledged as 
collateral, and covenants to reduce debt, 
and maintain working capital)?
[FASCON 5, par. 11; FASCON 1, par. 41; SFAS 
5, par. 18 (AC C59.120); SAS 32, par. 2 (AU 
431.02)]
2. Are the combined aggregate amount of 
maturities and sinking fund requirements for 
all long-term borrowings disclosed for each 
of the five years following the date of the 
latest balance sheet presented?
[SFAS 47, par. 10b (AC C32.105b)]
3. If the note is noninterest bearing or has an 
inappropriate stated interest rate:
a. Is the discount or premium presented as a 
deduction from or addition to the face 
amount of the note?
b. Does the disclosure include the effective
interest rate and face amount of the note? _____
c. Is amortization of the discount or premium
reported as interest expense? _____
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d. Are issue costs reported in the balance 
sheet as deferred charges?
[APB 21, par. 16 (AC I69.109)]
4. Are debt conversion features (such as rates 
and pertinent dates) disclosed?
[FASCON 5, par. 11; FASCON 1, par. 41; APB 
14, (AC D10); SAS 32, par. 2 (AU 431.02)]
5. Are current portions of debt obligations 
presented as current liabilities in a 
classified balance sheet?
[ARB 43, Ch. 3A, pars. 7-8 (AC 
B05.108-.109)]
6. If a short-term obligation is to be excluded 
from current liabilities in a classified 
balance sheet, do disclosures include;
a. General description of the financing 
agreement?
b. Terms of any new obligation incurred or 
expected to be incurred, or equity 
securities issued or expected to be issued 
as a result of the refinancing?
[SFAS 6, par. 15 (AC B05.118)
7. For troubled debt restructuring occurring 
during the current period, do disclosures 
include:
a. Description of the principal changes in 
terms and/or the major features of 
settlement?
b. Aggregate gain on restructuring of 
payables and the related income tax 
effect?
c. Aggregate net gain or loss on transfers of 
assets recognized during the period?
d. Per share amount, if applicable, of the 
aggregate gain on restructuring of 
payables, net of related income tax 
effect?
[SFAS 15, par. 25 (AC D22.121)]
18
Yes No N/A
8. For periods after a troubled debt 
restructuring, do disclosures include:
a. Extent to which amounts contingently 
payable are included in the carrying
amount of restructured payables? _____
b. Total amounts contingently payable, if 
applicable, and conditions under which 
those amounts would become payable or 
forgiven?
[SFAS 15, par. 26 (AC D22.122)] _____
9. Has debt, as required, been considered 
extinguished for financial reporting 
purposes because:
a. The debtor is legally released from being 
the primary obligor, and it is probable 
that the debtor will not be required to 
make future payments with respect to that
debt under any guarantee? _____
b. The debtor irrevocably places cash or 
other assets in a trust to be used solely 
for satisfying scheduled payments of both 
interest and principal of a specific 
obligation, and the possibility that the 
debtor will be required to make future 
payments with respect to that debt is 
remote?
[SFAS 76, par. 3 (AC D14.102A)? TB 85-2
(AC C30)] _____
10. If there is an early extinguishment of debt, 
is the difference between reacquisition 
price and carrying amount identified as a 
separate or extraordianry item?
[SFAS 4, par. 8 and SFAS 64, par. 4 (AC 
D14.105)] _____
11. If debt is considered to be extinguished 
early, do disclosures include:
a. A general description of the transaction? _____
b. The amount of debt that is considered 
extinguished as long as the debt remains
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outstanding?
[SFAS 76, par. 6 (AC D14.108)]
12. Are long-term obligations that are or will 
be callable by the creditor, either because 
the debtor’s violation of the debt agreement 
at the balance sheet date makes the 
obligation callable, or because the 
violation (if not cured within a specified 
grace period) will make the obligation 
callable, classified as current unless one 
of the following conditions is met:
a. The creditor has waived or subsequently 
lost the right to demand repayment for 
more than one year (or operating cycle, if 
longer) from the balance sheet date?
b. The obligation contains a grace period 
within which the debtor may cure the 
violation and it is probable that the 
violation will be cured within that 
period, thus preventing the violation from 
becoming callable?
[SFAS 78, par. 5 (AC B05.109A)]
13. Did the not-for-profit provider report 
tax-exempt obligations that were issued for 
its benefit as liabilities in the general 
funds?
[AAG, par. 9.04]
14. Has consideration been given to the effects, 
if any, of current and prior tax 
examinations on the financial statements and 
disclosures related to the existence of 
contingent liabilities for unrelated 
business income tax, additional payroll tax 
liabilities, or penalties and interest on 
delinquent taxes?
15. Has disclosure been considered for any 
changes in the provider’s activities that 
could affect its tax-exempt status?
16. Are disclosures appropriate regarding the 
provider’s tax-exempt status and any other 
significant tax matters?
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17. Is appropriate disclosure made if unrelated 
business income tax has not been accrued on 
income from:
a. Debt-financed investments that are not 
functionally related to the exempt 
purpose?
b. Certain related entities not engaged in an 
exempt activity?
c. Pharmacy operations in a medical building 
for the convenience of physicians' private 
patients?
d. A gift shop, cafeteria or food shop that 
the provider encourages the general public 
(except patients, visitors and employees) 
to use?
e. A parking lot available to the general 
public (except patients, visitors and 
employees)?
18. Has consideration been given to disclosing 
the effects of the Tax Reform Act of 1986 
which added new arbitrage restrictions 
regarding tax-exempt bonds?
[AAG, pars. 9.19-.33; SFAS 5, pars. 9-10 (AC 
C59.108-.lll)]
VII. COMMITMENTS AND CONTINGENCIES
A. Uninsured Medical Malpractice Claims
1. If a minimum amount of a probable loss 
(usually associated with litigating or 
setting malpractice claims) has been 
accrued, is there disclosure as to a 
reasonable possibility of an additional 
potential loss in excess of the amount 
accrued?
2. If a range of loss cannot be reasonably 
estimated is a contingency disclosed?
[AAG, par. 10.04; SFAS 5(AC C59)]
3. Are accrued unpaid claims and expenses
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expected to be paid during the normal
operating cycle classified as current
liabilities? __  _____  ____
4. Is the program of medical malpractice 
coverage and basis for loss accruals 
disclosed?
[AAG, par. 10.11; SFAS 5(AC C59)] _____
5. If the provider discounts accrued 
malpractice claims, are the following 
disclosed?
a. The carrying amount of the claims. _____
b. The interest rates or other rates used to 
discount the claims.
AAG, par. 10.12 _____
B. Retrospectively Rated Premiums
1. If the provider cannot estimate losses from 
asserted or unasserted malpractice claims, 
is the existing contingency disclosed?
[AAG, par. 10.14; SFAS 5(AC C59)] _____
2. Has the provider disclosed that it is 
insured under a retrospectively rated
policy? _____
3. Has the provider disclosed that premiums are
accrued based on the ultimate cost of the 
experience to date of a group of entities? _____
4. If losses cannot be estimated, is the 
existing contingency disclosed?
[AAG, par. 10.15; SFAS 5(AC C59)] _____
C. Medical Malpractice Claims Insured With 
Captive Insurance Companies (Controlled by a 
parent entity for the main purpose of 
providing insurance for the parent.)
1. Has the provider disclosed that it is 
insured under a retrospectively rated policy
of a multiprovider captive? _____
2. Has the provider disclosed that premiums are
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accrued based on the captive’s experience to 
date?
AAG, par. 10.18
3. Is the provider's ownership percentage in 
the captive disclosed?
4. Is the method of accounting for its 
investment in and the operations of the 
captive disclosed?
[AAG, par. 10.19]
5. If the provider cannot make the necessary 
estimates of losses from asserted or 
unasserted claims, Has it disclosed the 
existing contingency?
[AAG, par. 10.19; SFAS 5 (AC C59)]
D. Trust Funds
1. If trust funds (revocable or irrevocable) 
are included in the provider's financial 
statements;
a. Is a portion of the funds (the amount of 
assets expected to be liquidated to pay 
malpractice claims classified as current 
liabilities) classified as a current asset 
in a classified balance sheet?
b. Is the balance of the funds, if any, 
classified as a noncurrent asset in a 
classified balance sheet?
c. Are trust fund revenue and administrative 
expenses included in the statement of 
revenues and expenses (statement of 
operations)?
[AAG, par. 10.20]
d. Are estimated losses from asserted and 
unasserted claims reported?
[AAG, par. 10.21]
e. Is the existence of trust funds and 
whether they are irrevocable disclosed? 
[AAG, par. 10.22]
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E. Prepaid Health Care Services
1. Health Care Costs
a. Is the basis for accruing health care 
costs disclosed?
b. Are significant business and contractual 
arrangements with hospitals, physicians, 
and other associated entities disclosed? 
[SOP 89-5 (AAG, app. B), par. 32]
2. Stop-Loss Insurance
a. Are receivables representing amounts 
recoverable from insurers reported as 
assets net of any valuation allowance?
b. Are the nature, amounts, and effects of 
significant stop-loss insurance contracts 
disclosed?
[SOP 89-5 (AAG, app. B), par. 49]
F. Other Disclosures
1. Are the nature and, if applicable, amount 
(or a statement that no loss estimate can be 
made) disclosed for loss contingencies 
(including guarantees)?
[SFAS 5, pars. 9-12 and FASBI 34, pars. 2-3 
(AC C59.108-.114)]
2. Are gain contingencies adequately disclosed, 
with care to avoid misleading implications 
as to the likelihood of realization?
[SFAS 5, par. 17 (AC C59.118)]
3. Are the nature, term, amount and other 
required information disclosed for long-term 
unconditional purchase obligations?
[SFAS 47, pars. 7 and 10a (AC C32.102 and 
.105a)]
4. Are disclosures adequate for other 
commitments and contingencies that are 
similar to those of other business 
organizations?
[AAG, par. 10.25; SFAS 5, pars. 4, 7 and 18 
(AC C59.118, .120 and .122)]
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VIII. NET ASSETS (EQUITY OR FUND BALANCES)
A. Financial Statement Presentation
1. Are the equity accounts of investor-owned 
providers accounted for similarly to other 
investor-owned businesses?
2. Are the net assets of not-for-profit and 
governmental providers (that use the 
disaggregated method) displayed as general 
and donor-restricted fund balances?
3. Are the net assets of not-for-profit and 
governmental providers (that use the 
aggregated method) displayed as 
unrestricted, temporarily restricted or 
permanently restricted fund balances as 
appropriate?
[AAG, par. 11.01]
4. Is the nature of restrictions on 
donor-restricted resources disclosed?
[AAG, par. 11.02]
5. Shareholders' Equity (Corporations)
a. For each class of stock, do disclosures 
include the number of shares authorized, 
issued and outstanding, and par or stated 
value per share?
[APB 4, par. 199, R-9A]
b. Do the financial statements include a 
description, in summary form, sufficient 
to explain the pertinent rights and 
privileges of the various securities 
outstanding, for example: dividend and 
liquidation preferences, participation 
rights, call prices and dates, conversion 
or exercise prices or rates and pertinent 
dates, sinking fund requirements, unusual 
voting rights?
[APB 15, par. 19 (AC E09.110)]
c. Are liquidation preferences of preferred 
stock issues prominently disclosed in the 
equity section of the balance sheet in the 
aggregate?
[APB 10, par. 10 (AC C16.101)]
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d. For preferred stock, do disclosures 
include:
(1).  Aggregate or per share amounts at which
shares may be called or are subject to 
redemption?
[APB 10, par. 11 (ACC16.102)] _____
(2).  Aggregate and per share amounts of
arrearages in cumulative preferred 
dividends?
[APB 15, par. 50, fn. 16 (AC C16.102)] _____
e. For stock option and stock purchase plans, 
do disclosures include:
(1).  Number of shares under option? _____
(2).  Option price? _____
(3).  Number of shares as to which options are
exercisable? _____
(4).  For options exercised, the number of 
shares involved and option price?
[ARB 43, Ch. 13B, par. 15 (AC C47.123)] _____
f. Are any appropriations of retained 
earnings for loss contingencies clearly 
identified and included in stockholders’ 
equity?
[SFAS 5, par. 15 (AC R70.103)] _____
g. Are restrictions on payment of dividends 
disclosed?
[SFAS 5, pars. 18-19 (AC C59.120)] _____
h. Are receivables for stock issued or 
subscribed appropriately identified and 
presented as a deduction from capital or, 
if presented as an asset, stated 
separately, clearly labeled, and their 
status clearly described to distinguish
them from any other type of assets? _____
i. Are the amounts of redemption requirements 
for all issues of capital stock that are 
redeemable at fixed or determinable prices
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on fixed or determinable dates disclosed 
for each of the five years following the 
date of the latest balance sheet 
presented?
[SFAS 47, par. 10 (AC C32.105)]
6. Changes in Net Assets (Fund Balances)
a. When both financial position and results 
of operations (or revenue and expenses of 
general funds) are presented:
(1).  Are changes in the separate component
accounts of equity (or fund balances) 
disclosed?
[APB 12, par. 10 (AC C08.102); AAG, par. 
3.24]
(2).  Are changes in the number of shares of
capital stock disclosed for at least the 
latest year and any subsequent interim 
periods presented?
[APB 12, par. 10 (AC C08.102)]
b. Are prior period adjustments and their 
resulting effects (both gross and net of 
applicable income taxes) appropriately 
presented and disclosed?
[APB 9, par. 26 (AC A35.107)]
c. If an additional pension liability is 
required to be recognized and exceeds 
unrecognized prior service cost, has the 
excess (which would represent a net loss 
not yet recognized as net periodic pension 
cost) been reported as a separate 
component (that is, a reduction) of equity 
net of any tax benefits that result from 
considering such losses as temporary 
differences?
[SFAS 87, par. 37 (AC P16.131)]
IX. REVENUES, EXPENSES, GAINS AND LOSSES
A. Conceptual Framework for Reporting and
Classification
1. Are revenues and expenses (arising from
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ongoing activities associated with health 
care services) classified as operating and 
displayed as gross amounts?
2. Has display of gains and losses [resulting 
from peripheral or incidental transactions 
and from other events (environmentally 
related and largely uncontrollable)] as net 
amounts been considered?
[AAG, pars. 12.01 -.02]
3. Are gains and losses classified in relation 
to major ongoing or central operations such 
as:
a. Operating if related?
b. Nonoperating if peripheral, incidental or 
unrelated?
[AAG, sec. 12.03]
4. For investments in common stock accounted 
for by the equity method, is the investor's 
share of earnings shown as a single amount 
except for investee extraordinary items and 
prior period adjustments that are material 
to the investor?
[APB 18, pars. 19c-d (AC I82.109c-d)]
5. Are total research and development costs 
charged to expense disclosed for each period 
to which a statement of revenues and 
expenses [operations] is presented?
[SFAS 2, pars. 12-13 (AC R50.108-.109)?
FASBI 4, par. 5 (AC B50.152); FASBI 6, par.
8 (AC R50.117); SFAS 68, par. 14 (AC 
R55.112); SFAS 86, par. 3 (AC Co2.102)]
6. Is the amount of interest cost incurred 
disclosed in the statements or notes 
thereto, and for an accounting period in 
which some interest cost is capitalized, the 
total amount thereof that has been 
capitalized?
[SFAS 34, par. 21 (AC I67.118)]
7. If there is a compensatory stock issuance 
plan, are disclosures adequate?
[ARB 43, Ch. 13B, par. 15 (AC C47.123)]
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8. If the provider accounts for its obligation 
under a research and development arrangement 
as a contract to perform research and 
development for others, is there disclosure 
of:
a. The terms of significant agreements under 
the research and development arrangement 
as of the date of each balance sheet 
presented?
b. The amount of compensation earned or costs 
incurred under such contracts for each 
period for which a statement of revenues 
and expenses [statement of operations] is 
presented?
[SFAS 68, par. 14 (AC R55.112)]
B. Revenue
1. Is revenue classified based on the type of 
service (such as patient or resident) 
rendered or contracted to be rendered?
[AAG, par. 12.04]
2. Are contributions, tax support and other 
subsidies classified as:
a. Gains, when peripheral or incidental to 
health care activities?
b. Revenues, if deemed ongoing major or 
central activities to provide health care 
services?
[AAG, par. 12.05]
3. Is other revenue (such as from sales and 
services, other than health care, to 
patients, residents, nonpatients or 
visitors):
a. Classified as operating?
b. Stated separately?
[AAG, pars. 12.06 -.07]
4. Have gains and losses been properly 
classified and reported?
[AAG, par. 12.08]
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C. Financial Statement Presentation
1. Is service revenue reported net of 
contractual charity care and other 
adjustments?
[AAG, par. 12.11]
2. Do disclosures include the methods of:
a. Revenue recognition?
b. Recording unrestricted and restricted 
donations and investment income of both 
general and restricted funds?
3. With regard to contractual adjustments and 
third-party settlements, did the provider 
identify and explain the estimated amounts 
payable or receivable?
[AAG, par. 12.13]
4. Are expenses incurred to solicit 
contributions separately disclosed?
[AAG, par. 12.16]
5. Income Taxes
a. Have the types of significant temporary 
differences and carryforwards been 
disclosed?
[SFAS 109, par. 43 (AC I27.142)]
b. Are the following significant components 
of income tax expense attributable to 
continuing operations for each year 
presented disclosed in the financial 
statements or notes thereto?
(1).  Current tax expense or benefit.
(2).  Deferred tax expense or benefit
(exclusive of the effects of other 
components listed below).
(3).  Investment tax credits.
(4).  Government grants (to the extent
recognized as a reduction of income tax 
expense).
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(5).  The benefits of operating loss
carryforwards.
(6).  Tax expense that results from allocating
certain benefits either directly to 
contributed capital or to reduce 
goodwill or other noncurrent intangible 
assets of an acquired entity.
(7).  Adjustments of a deferred tax liability
or asset for enacted changes in tax laws 
or rates or a change in the tax status 
of the provider.
(8).  Adjustments of the beginning-of-the-year
balance of a valuation allowance because 
of a change in circumstances that causes 
a change in judgment about the
realizability of the related deferred 
tax asset in future years.
[SFAS 109, par. 45 (AC I27.144)]
c. Are the amount of income tax expense or 
benefit allocated to continuing operations 
and the amounts separately allocated to 
other items disclosed for each year for 
which those items are presented?
[SFAS 109, pars. 35-39 and 46 (AC 
I27.134-.138 and .145)]
d. Is the nature of significant reconciling 
items disclosed?
[SFAS 109, par. 47 (AC I27.146)]
e. Are the amounts and expiration dates of 
operating loss and tax credit carry­
forwards for tax purposes disclosed?
[SFAS 109, par. 48 (AC I27.147)]
f. If the provider is a member of a group 
that files a consolidated tax return, are 
the following items disclosed in its 
separately issued financial statements:
(1).  The aggregate amount of current and 
deferred tax expense for each period 
presented, and the amount of any 
tax-related balances due to or from 
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affiliates as of the date of each 
balance sheet presented.
(2).  The method by which the consolidated 
amount of current and deferred tax 
expense is allocated to members of the 
group and the nature and effect of any 
changes in that method (and in 
determining related balances to or from 
affiliates) for each period presented. 
[SFAS 109, par. 49 (AC I27.148)]
g. Is the effect of initially applying SFAS 
109 [AC I27] reported as the effect of a 
change in accounting principle in a manner 
similar to the cumulative effect of a 
change in accounting principle, except for 
initially recognized tax benefits of the 
type required to be excluded from 
comprehensive income.
[APB 20, par. 20 (AC A06.116); SFAS 109, 
par. 51]
h. When initially presented, have the 
financial statements for the year SFAS 109 
[AC I27] is first adopted disclosed the 
following:
(1).  The effect, if any, of adopting SFAS 109
on continuing operations before income 
taxes (for example, the effect of 
adjustments for prior purchase business 
combinations and for regulated 
enterprises) for the year of adoption if 
restated financial statements for the 
prior year are not presented?
(2).  The effect of any restatement on
continuing operations, income before 
extraordinary items, and net income (and 
related per share amounts, if
applicable) for each year for which 
restated financial statements are 
presented?
[SFAS 109, par. 52]
6. Discontinued Operations
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a. Are operations of a segment that has been 
discontinued or is the subject of a formal 
plan for disposition:
(1).  Reported separately from continuing
operations and as a component (including 
applicable income taxes) of operations 
before extraordinary items? _____
(2).  Accompanied by disclosure in the notes
of revenue applicable to the
discontinued operations? _____
b. Is gain or loss from disposal of a 
discontinued segment reported separately 
(including applicable income taxes) in 
conjunction with results of discontinued 
operations as a component of income before 
extraordinary items?
[APB 30, pars. 8, 13 and 15-18 (AC
I13.101-.103 , .105-.106 and .108-.109)] _____
c. For the period encompassing the 
measurement date, do notes to financial 
statement disclose:
(1).  Identity of the segment discontinued? _____
(2).  Expected disposal date, if known? _____
(3).  Expected manner of disposal? _____
(4).  Description of the remaining assets and
liabilities of the discontinued segment 
at the balance sheet date?
(5).  Results of operations and any proceeds 
from disposal of the discontinued 
segment during the period from the 
measurement date to the balance sheet 
date?
[APB 30, par. 18 (AC I13.108-.109)]
d. For periods after the measurement date and 
including the disposal, do notes to 
financial statements disclose the 
information required for the period 
encompassing the measurement date and the
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actual date and results of disposal 
compared with the prior estimates?
[APB 30, par. 18 (AC I13.108-.109)]
7. Extraordinary Items
a. Do extraordinary items meet both criteria 
of (1) an unusual nature and (2) 
infrequency of occurrence?
[APB 30, pars. 19-24 (AC I17.106-.lll and 
.118)]
b. Are extraordinary items segregated and 
shown (including applicable income taxes) 
after income before extraordinary items 
and before net income?
[APB 30, par. 10-12 (AC I17.102-.103)]
c. Are descriptive captions and amounts 
(including applicable income taxes) 
presented for individual extraordinary 
events or transactions, preferably on the 
face of the income statement, if 
practicable?
d. Do disclosures include descriptions of 
extraordinary events or transactions and 
the principal items entering into 
determination of extraordinary gains or 
losses?
[APB 30, par. 11 (AC I17.102)]
e. For gains or losses from extinguishment of 
debt classified as extraordinary items, do 
disclosures include:
(1).  Description of the extinguishment
transactions, including the sources of 
any funds used to extinguish the debt if 
it is practicable to identify the 
sources?
(2).  Income tax effect in the period of
extinguishment?
(3).  Per share amount (if applicable) of the
aggregate gain or loss net of related 
income tax effect?
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[SFAS 4, pars. 8-10 (AC I17.104 and 
D14.105-.107)] _____
f. For an adjustment of an extraordinary item 
reported in a prior period (except for 
correction of an error):
(1).  Is the adjustment classified separately
as an extraordinary item in the current 
period? _____
(2) Are the nature, origin and amount of the
item disclosed?
[SFAS 16, par. 16(c) (AC I17.119)] _____
8. Are material events or transactions that are 
either unusual in nature or of infrequent 
occurrence but not both (and therefore not 
meeting criteria for extraordinary items):
a. Reported as a separate component of income
from continuing operations? _____
b. Accompanied by disclosure of the nature 
and financial effects of each event?
[APB 30, par. 26 (AC I22.101)] _____
X. STATEMENT OF CASH FLOWS
A. Is a statement of cash flows presented as a 
basic financial statement for each period for 
which a statement of revenues and
expenses (statement of operations) is 
presented for:
1. General funds of a not-for-profit or
governmental entity? _____
2. Restricted funds of a governmental entity? _____
3. Any investor-owned entity?
[SFAS 95, par. 3 (AC C25.101); AAG, pars.
3.24-.25] _____
B. Does the statement of cash flows explain the 
effect of cash flows by showing the change in 
cash and cash equivalents?
[SFAS 95, par. 7 (AC C25.105)] _____
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C. Is the policy for defining cash equivalents 
disclosed?
[SFAS 95, par. 10 (AC C25.108)]
D. If the direct method is used, has a 
reconciliation of the excess of revenues and 
expenses [income] to net cash flow from 
operating activities been provided in a 
separate schedule?
[SFAS 95, par. 30 (AC C25.128)]
E. If the indirect method is used:
1. Has the same amount for net cash flow from 
operating activities been reported 
indirectly by adjusting the excess of 
revenues and expenses [income] to reconcile 
it to net cash flow from operating 
activities?
[SFAS 95, par. 28 (AC C25.126)]
2. Has the reconciliation of the excess of 
revenues and expenses [income] to net cash 
flow from operating activities been reported 
either within the statement of cash flows or 
provided in a separate schedule, with the 
statement of cash flows reporting only the 
net cash flow from operating activities? 
[SFAS 95, par. 30 (AC C25.128)]
F. Are cash receipts and cash payments for the 
following transactions classified as cash 
flows from operating activities:
1. Interest received on loans?
2. Insurance proceeds except those directly 
related to investing or financing 
activities?
3. Interest paid to creditors?
4. Payments to suppliers and employees?
5. Payments to governments for taxes, duties, 
fines, and other fees or penalties?
6. Payments to settle lawsuits?
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Yes
7. Contributions to charities?
[SFAS 95, pars. 22-23 (AC C25.120-.121)]
G. Are cash receipts and cash payments for the 
following transactions classified as cash 
flows from investing activities:
1. Receipts from collections or sales of loans? _____
2. Receipts from sales of property? _____
3. Loans to others? _____
4. Payments to acquire property?
[SFAS 95, pars. 16-17 (AC C25.114-.115)]
H. Are cash receipts and cash payments for the 
following transactions classified as cash 
flows from financing activities:
1. Proceeds from issuing debt?
2. Repayments for amounts borrowed?
[SFAS 95, pars. 19-20 (AC C25.117-.118)]
I. Except for certain items whose turnover is 
quick, amounts are large and maturities are 
short, are cash receipts and cash payments 
from investing and financing activities shown 
separately on the statement of cash flows? 
[SFAS 95, pars. 12-13 and 31 (AC C25.110-.lll 
and .129)]
J. Are noncash investing and financing activities 
(such as converting debt to equity) summarized 
in a separate schedule or the notes?
[SFAS 95, par. 32 (AC C25.134)]
XI. RELATED ORGANIZATIONS AND ECONOMIC DEPENDENCY
A. Business Combinations
1. If a business combination occurred during 
the period and met the specified conditions 
for a pooling of interests:
[APB 16, pars. 45-48 (AC B50.104-.107)] 
a. Has the required accounting method been
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No N/A
Yes No N/A
applied?
[APB 16, pars. 50-62 (AC B50.109-.121)]
b. Do the statements and notes include the 
required disclosures?
[APB 16, pars. 63-65 (AC B50.122-.124)] _____
2. If a business combination does not meet the 
specified conditions for a pooling of 
interests:
a. Has the combination been accounted for by 
the purchase method?
[APB 16, pars. 66-88 and 90-94 (AC 
B50.125-.146 and .159-.163); SFAS 87, 
pars. 74, 253 and 387 (AC B50.146j and 1);
SFAS 106, pars. 86-88 (AC B50.106k);
SFAS 109, pars. 288d and q (AC B50.1461 
and .148); SFAS 38 (AC B50.148-.150);
FASBI 4, pars. 4-5 (AC B50.151-.152)] _____
b. Do the statements and notes include the 
required disclosures as applicable?
[APB 16, pars. 95-96 (AC B50.164-.165);
SFAS 79, par. 6 (AC B50.165); SFAS 38,
par. 10 (AC B50.166)] _____
3. Has any portion of the valuation allowance 
for deferred tax assets for which 
subsequently recognized tax benefits will be 
allocated to reduce goodwill or other 
noncurrent intangible assets of an acquired 
entity, or directly to contributed capital 
been disclosed?
[SFAS 109, pars. 30, 36 and 48 (AC I27.129,
.135 and .147)] _____
B. Consolidation and Combination
1. If the provider and another entity are 
related and they meet the criteria for 
consolidation or combination
("consolidation”), are consolidated or 
combined ("consolidated") financial 
statements presented?
[AAG, par. 13.2; ARB 51 (AC C51); SFAS 94
(AC C51)] _____
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Yes
2. If consolidated statements are presented:
a. Is the consolidation policy disclosed?
[ARB 51, par. 5 (AC C51.108); APB 22, par. 
13 (AC A10.106)]
b. Are intercompany balances and transactions 
eliminated?
[ARB 51, par. 6 (AC C51.109)]
c. When the financial reporting periods of 
consolidated entities differ, is 
recognition given, by disclosure or 
otherwise, to the effect of intervening 
events that materially affect financial 
position or results of operations?
[ARB 51, par. 4 (AC C51.107); SFAS 12, 
pars. 18-20 (AC I89.112-.114); FASBI 13, 
pars. 6-8 (AC I89.120-.122)]
3. If the parent company has realized gains or 
losses of marketable securities in 
operations and a consolidated subsidiary 
does not, has the subsidiary’s accounting 
treatment for marketable securities been 
conformed with that of the parent?
[SFAS 12, par. 18 (AC I89.112)]
4. If the parent follows specialized accounting 
practices for marketable securities and the 
consolidated subsidiaries do not, are the 
subsidiaries' current and noncurrent 
portfolios consolidated as separate current 
and noncurrent portfolios exclusive of the 
parent and is the required information 
disclosed?
[SFAS 12, pars. 12 and 19 (AC I89.106 and 
.113)]
5. If the consolidated financial statements 
include more than one accepted practice of 
accounting for marketable securities, are 
the required disclosures made for the 
various methods?
[SFAS 12, par. 20 (AC I89.114)]
6. Do disclosures about formerly unconsolidated 
subsidiaries, that are now consolidated,
39
No N/A
Yes No N/A
include summarized information about the 
assets, liabilities, and results of 
operations (or separate statements) in the 
consolidated financial statements or notes? 
[AAG, par. 13.2; SFAS 94, par. 14 (AC 
C51.120A)]
C. Related Parties and Economic Dependency
1. If the entity does not meet the criteria for 
consolidation or combination, but controls 
and is the sole beneficiary of a related 
organization’s activities, is summarized 
financial data of the related organization 
disclosed?
[AAG, pars. 13.3-.4]
2. For any related party that is not 
consolidated or combined, did the entity 
disclose (even if there are no transactions 
between them):
a. The nature of the relationship between the 
entity and the related party?
b. If there have been material transactions 
between the entity and the related party:
(1).  A description of the transactions,
including transactions to which nominal 
or no amounts were ascribed?
(2).  The amount of such transactions?
(3).  Amounts due from or to the related party
and, if not apparent, the terms and 
manner of settlement?
[AAG, pars. 13.03-.05; SFAS 13, par. 29 
(AC L10.125); SFAS 57, pars. 2-4 
(AC R36.102-.104)]
XII. CONTINUING CARE RETIREMENT COMMUNITIES (CCRCs)
A. Refundable Advance Fees
1. Is the estimated amount of advance fees
expected to be refunded to current residents 
reported as a liability?
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Yes
2. Is the remaining amount of advance fees 
reported in the balance sheet as deferred 
revenue?
3. Are the following disclosed:
a. The gross amount of contractual refund 
obligations under existing contracts?
b. The CCRC’s refund policy?
4. Are amounts refunded disclosed in the 
statement of cash flows as a financing 
transaction?
[SOP 90-8 (AAG, app. C), par. 22]
5. Is the method of accounting, including the 
amortization method, for deferred revenue 
disclosed?
[AAG, par. 9.34; SOP 90-8 (AAG, app. C), 
pars. 23, 31 and 43]
B. Fees Refundable to Residents Only From 
Reoccupancy Proceeds of a Contract Holder’s 
Unit
1. Are the following reported as deferred 
revenue:
a. The portion of fees to be paid to current 
residents or their designees, only to the 
extent of a contract holder’s unit 
reoccupancy proceeds, if law and 
management policy and practice support the 
withholding of refunds under this 
condition?
b. Similar amounts received from new 
residents in excess of the amount to be 
paid to previous residents or their 
designees?
[SOP 90-8 (AAG, app. C), par. 31]
C. Nonrefundable Advance Fees
1. Are nonrefundable advance fees reported as 
deferred revenue?
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2. Is unamortized deferred revenue reported as 
revenue upon a resident’s death or contract 
termination?
[SOP 90-8 (AAG, app. C), pars. 23 and 43]
D. Obligation to Provide Future Services and Use 
of Facilities to Current Residents
1. If the obligation to provide future services 
and use of facilities to current residents 
under continuing-care contracts results in a 
liability, are the following disclosed:
a. The carrying amount of the liability?
b. The interest rate used to discount that 
liability?
[SOP 90-8 (AAG, app. C), par. 55]
E. Costs of Acquiring Initial Continuing-Care 
Contracts
1. Are costs of acquiring initial 
continuing-care contracts capitalized if 
they are expected to be recovered from 
future contract revenues?
2. Are continuing-care contract acquisition 
costs expensed if incurred after a) the CCRC 
is substantially occupied or b) one year 
following completion?
[SOP 90-8 (AAG, app. C), par. 63]
XIII. FINANCIAL STATEMENTS AND NOTES - GENERAL
A. Titles and References
1. Are the financial statements suitably 
titled?
[SAS 62, par. 7 (AU 623.07)]
2. Does each statement include a general 
reference that the notes are an integral 
part of the financial statement
presentation?
3. Do the note captions and the referencing 
from the applicable statement
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Yes No N/A
classifications seem appropriate? 
[FASCON, par. 18]
B. Disclosure of Accounting Policies
1. Is a description of all pertinent accounting 
policies of the provider presented as an 
integral part of the financial statements? 
[APB 22, pars. 8-9 (AC A10.102-.103)]
2. Does disclosure of significant accounting 
policies encompass important judgments as to 
appropriateness of principles concerning 
recognition of revenue, and allocation of 
asset costs to current and future periods? 
[APB 22, par. 12 (AC A10.105)]
3. Does the disclosure of significant 
accounting policies include appropriate 
reference to details presented elsewhere (in 
the statements and notes thereto) so 
duplication of details is avoided?
[APB 22, par. 14 (AC A10.107)]
C. Accounting Changes
1. For an accounting change, does disclosure in 
the period of the change include:
a. Nature of the change?
b. Justification for the change including a 
clear explanation why the newly adopted 
principle is preferable?
c. Effect on income?
[APB 20, par. 17 (AC A06.113)]
2. For changes in accounting principle 
(excluding specific exceptions related to an 
initial public offering, change in the 
reporting entity, or adoption of certain 
authoritative pronouncements):
a. If comparative financial statements are
included, are they presented as previously 
reported?
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Yes No N/A
b. Is the cumulative effect of the change 
(direct effects and income tax effects 
only) on beginning retained earnings for 
the period of the change shown in the 
statement of revenues and expenses 
[statement of operations] of that period, 
after any extraordinary items and before 
net revenue and gains in excess of 
expenses and losses [net income]?
c. Is the effect of adopting the new 
accounting principle on revenue and gains 
in excess of expenses and losses [income] 
before extraordinary items and net revenue 
and gains in excess of expenses and losses 
[net income] (and applicable per share 
data) disclosed for the period of the 
change?
d. Are pro forma revenues and gains in excess 
of expenses and loss [income] before 
extraordinary items and net revenue and 
gains in excess of expenses and losses 
[net income] shown on the face of the 
statement of revenue and expenses 
[statement of operations] for all periods 
presented as if the newly adopted 
accounting principle had been applied 
during all periods affected?
e. If pro forma amounts or cumulative effects 
cannot be determined, are the reasons 
disclosed?
[APB 20, pars. 12, 17-22, 24-26, 29 and 34 
(AC A06.113-.118, .120-.122 and .125, and
A35.112 and .114); FASBI 20, par. 5 
(A06.127)]
3. Is the correction of an error shown as a 
prior period adjustment with disclosure of 
the following in the period of its discovery 
and correction:
a. Nature of the error in previously issued 
financial statements?
b. Effect of its correction on revenue and 
gains in excess of expenses and losses
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[income] before extraordinary items and 
net revenue and gains in exces of expenses 
and losses [net income] (and related per 
share amounts if applicable)?
[APB 20, par. 36 (AC A35.105); SFAS 109, 
par. 288n (AC A35.103)]
D. Comparative Financial Statements
1. Have comparative statements been considered? 
[ARB 43, Ch. 2A, pars. 1-2 (AC F43.101- 
.102)]
2. Are the notes and other disclosures included 
in the financial statements of the preceding 
year(s) presented, repeated or at least 
referred to, to the extent that they 
continue to be of significance?
[ARB 43, Ch. 2A, par. 2 (AC F43.102)]
3. If changes have occurred in the manner of or 
basis for presenting corresponding items for 
two or more periods, are appropriate 
explanations of the changes disclosed?
[ARB 43, Ch. 2A, par. 3 (AC F43.103)]
E. Financial Instruments
1. Except for certain excluded items [SFAS 105, 
pars. 14-15 (AC F25.104-.105)], are the 
following disclosed in the financial 
statements or notes for each class of 
financial instruments with off-balance-sheet 
risk?
a. The face or contract amount, or notional 
principal amount if there is no face or 
contract amount?
b. The nature and terms, including, at a 
minimum, a discussion of:
(1).  Credit and market risk of those 
instruments?
(2).  Cash requirements of those instruments? _____
(3).  Related accounting policy, as required
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by APB 22, Disclosure of Accounting 
Policies (AC A10)?
[SFAS 105, par. 17 (CT F25.112)] _____
2. For financial instruments with 
off-balance-sheet credit risk [except for 
the items excluded in SFAS 105, (AC F25)], 
are the following disclosed either in the 
financial statements or in the notes by 
class of financial instrument?
a. The amount of accounting loss the entity 
would incur if 1) any party to the 
financial instrument failed completely to 
perform according to the terms of the 
contract, and 2) the collateral or other 
security, if any, for the amount due
proved to be of no value to the entity. _____
b. Regarding collateral or other security to 
support financial instruments subject to 
credit risk:
(1).  The entity’s policy of requiring such
collateral or other security. _____
(2).  Information about the entity’s access to
that collateral or other security. _____
(3).  The nature and a brief description of
the collateral or other security 
supporting those financial instruments.
[SFAS 105, par. 18 (AC F25.113)] _____
3. Do disclosures of all significant 
concentrations of credit risk arising from 
all financial instruments, whether from an 
individual counterparty or groups of 
counterparties (except for certain insurance 
and investment contracts, purchase and 
pension obligations and substantively 
extinguished debt), include:
a. Information about the (shared) activity, 
region, or economic characteristic that 
identifies the concentration? _____
b. The amount of the accounting loss due to
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credit risk the entity would incur if 1) 
parties to the financial instruments that 
make up the concentration failed
completely to perform according to the 
terms of the contracts and 2) the 
collateral or other security, if any, for 
the amount due proved to be of no value to 
the entity?
c. Regarding collateral or other security to 
support financial instruments subject to 
credit risk:
(1).  The entity’s policy of requiring such
collateral or other security?
(2).  Information about the entity's access to
that collateral or other security?
(3).  The nature and a brief description of
the collateral or other security 
supporting those financial instruments? 
[SFAS 105, pars. 14 and 20 (AC F25.104 
and .115)]
4. Is the fair value of financial instruments 
for which it is practicable to estimate that 
value (except for certain excluded items 
and trade receivables and payables whose 
amount approximates fair value) disclosed 
in the financial statements or accompanying 
notes?
5. Are the methods and significant assumptions 
used to estimate the fair value of financial 
instruments disclosed?
[SFAS 107, par 10 (AC F25.115C)]
6. If it is not practicable to estimate the 
fair value of a financial instrument, are 
the following disclosed?
a. Information pertinent to estimating the
fair value of that financial instrument or 
class of financial instruments, such as 
the carrying amount, effective interest 
rate, and maturity.
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No N/A
b. The reasons why it is not practicable to 
estimate fair value.
[SFAS 107, par. 14 (AC F25.115G)]
F. Nonmonetary Transactions
1. Do disclosures include:
a. Nature of the transactions?
b. Basis of accounting for the assets 
transferred?
c. Gains or losses recognized on the 
transfers?
[APB 29, par. 28 (AC C11.102 and N35.120)]
G. Subsequent Events
1. Are the financial statements adjusted for 
any changes in estimates resulting from 
subsequent events that provide additional 
evidence about conditions that existed at 
the balance sheet date?
[SFAS 5, par. 8 (AC C59.105); SAS 1, secs. 
560.03-.04, .07 and 561.01-.09 (AU
560.03-.04, .07 and 561.01-.09)]
2. Are subsequent events that provide evidence 
about conditions that did not exist at the 
date of the balance sheet but arose 
subsequent to that date adequately disclosed 
to keep the financial statements from being 
misleading?
[SFAS 5, par. 11 (AC C59.112); APB 16 (AC 
B50.120); SAS 1, secs. 560.05-.07, .09 and 
561.01-.09 (AU 560.05-.07, .09 and 
561.01-.09)]
H. Pension Plans
1. If there is a defined benefit plan, do 
disclosures include:
a. A description of the plan, including
employee groups covered, type of benefit 
formula, funding policy, types of assets 
held and significant nonbenefit
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Yes No N/A
Yes No N/A
liabilities, if any, and the nature and 
effect of significant matters affecting 
comparability of information for all 
periods presented?
b. The amount of net periodic pension cost 
for the period showing separately the 
service cost component, the interest cost 
component, the actual return on assets for 
the period, and the net total of other 
components?
c. A schedule reconciling the funded status 
of the plan with amounts reported in the 
employer's balance sheet, showing 
separately:
(1).  The fair value of plan assets?
(2).  The projected benefit obligation
identifying the accumulated benefit 
obligation and the vested benefit 
obligation?
(3).  The amount of unrecognized prior service
cost?
(4).  The amount of unrecognized net gain or
loss (including asset gains and losses 
not yet reflected in market-related 
value)?
(5).  The amount of any remaining unrecognized
net obligation or net asset existing at 
the date of initial application of SFAS 
87 [AC P16]?
(6).  The amount of any additional liability
recognized pursuant to SFAS 87, 
paragraph 36 [AC P16.130]?
(7).  The amount of net pension asset or
liability recognized in the balance 
sheet pursuant to SFAS 87, paragraphs 
35-36 [AC P16.129-.130] (which is the 
net result of combining the preceding 
six items)?
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Yes No N/A
d. The weighted-average assumed discount rate 
and rate of compensation increase (if 
applicable) used to measure the projected 
benefit obligation and the
weighted-average expected long-term rate 
of return on plan assets?
e. If applicable, the amount and types of 
securities of the employer and related 
parties included in plan assets, and the 
approximate amount of annual benefits of 
employees and retirees covered by annuity 
contracts issued by the employer and 
related parties. Also, if applicable, the 
alternative amortization methods used 
pursuant to SFAS 87, paragraphs 26 and 33 
[AC P16.120 and .127], and the existence 
and nature of the commitment discussed in 
paragraph 41 [AC P16.135]?
[SFAS 87, par. 54 (AC P16.150)]
f. If more than one defined benefit plan 
exists:
(1).  Have the disclosures required by Step
H.1. above been aggregated for all of 
the employee’s single-employer defined 
benefit plans or disaggregated in groups 
so as to provide the most useful 
information?
(2).  Are plans with assets in excess of
accumulated benefit obligations not 
aggregated with plans that have 
accumulated benefit obligations that 
exceed plan assets?
[SFAS 87, par. 56 (AC P16.153)]
2. If there are one or more defined
contribution plans, do disclosures include:
a. A description of the plans including 
employee groups covered, the basis for 
determining contributions, and the nature 
and effect of significant matters 
affecting comparability of information for 
all periods presented?
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b. The amount of cost recognized during the 
period?
[SFAS 87, par. 65 (AC P16.162)]
3. If the substance of a plan having 
characteristics of both defined benefits and 
contributions is to provide a defined 
benefit, are disclosures in accordance with 
the requirements applicable to a defined 
benefit plan as described in Step H.1. 
above?
[SFAS 87, par. 66 (AC P16.163)]
4. If there are one or more multiemployer 
plans, do disclosures include:
a. A description of the multiemployer plans 
including the employee groups covered, the 
type of benefits provided (defined benefit 
or defined contribution), and the nature 
and effect of significant matters
affecting comparability of information for 
all periods presented?
b. The amount of cost recognized during the 
period?
[SFAS 87, par. 69 (AC P16.166)]
5. If there is a settlement and/or curtailment 
of a defined benefit pension plan and/or 
termination benefits under such plan, do 
disclosures include:
a. A description of the nature of the 
event(s)?
b. The amount of gain or loss recognized? 
[SFAS 88, par. 17 (AC P16.187)]
I. Postretirement Benefits Other Than Pensions
1. If there are one or more defined benefit 
postretirement plans, do disclosures 
include:
a. A description of the substantive plans 
that is the basis for the accounting, 
including the nature of the plans, any
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modifications of the existing cost-sharing 
provisions that are encompassed by the 
substantive plans, and the existence and 
nature of any commitment to increase 
monetary benefits provided by the plans, 
employee groups covered, types of benefits 
provided, funding policy, types of assets 
held and significant nonbenefit 
liabilities, and the nature and effect of 
significant matters affecting the 
comparability of information for all 
periods presented, such as the effect of a 
business combination or divestiture?
b. The amount of net periodic postretirement 
benefit cost showing separately the 
service cost component, the interest cost 
component, the actual return on plan 
assets for the period, amortization of the 
unrecognized transition obligation or 
transition asset, and the net total of 
other components?
c. A schedule reconciling the funded status 
of the plans with amounts reported in the 
employer’s balance sheet, showing 
separately:
(1).  The fair value of plan assets?
(2).  The accumulated postretirement benefit
obligation, identifying separately the 
portion attributable to retirees, other 
fully eligible plan participants, and 
other active plan participants?
(3).  The amount of unrecognized prior service
cost?
(4).  The amount of unrecognized net gain or
loss (including plan asset gains and 
losses not yet reflected in 
market-related value)?
(5).  The amount of any remaining unrecognized
transition obligation or transition 
asset?
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(6).  The amount of net postretirement benefit 
asset or liability recognized in the 
balance sheet, which is the net result 
of combining the preceding five items? _____
d. The assumed health care cost trend rates 
used to measure the expected cost of 
benefits covered by the plan (gross 
eligible charges) for the next year and a 
general description of the direction and 
pattern of change in the assumed trend 
rate(s) thereafter, together with the 
ultimate trend rate(s) and when the rate
is expected to be achieved? _____
e. The weighted-average of the assumed 
discount rate(s) and rate(s) of 
compensation increase (for pay-related 
plans) used to measure the accumulated 
postretirement benefit obligation and the 
weighted-average of the expected long-term 
rate(s) of return on plan assets and, for 
plans whose income is segregated from the 
employer’s investment income for tax 
purposes, the estimated income tax rate(s) 
included in that rate of return?
f. The effect of a one-percentage-point 
increase in the assumed health care cost 
trend rates for each future year on:
(1).  The aggregate of the service and
interest cost components of net periodic 
postretirement health care benefit cost? _____
(2).  The accumulated postretirement benefit
obligation for health care benefits (for
purposes of this disclosure, all other
assumptions shall be held constant and
the effects shall be measured based on
the substantive plan that is the basis
for the accounting)? _____
g. The amounts and types of securities of the 
employer and related parties included in 
plan assets, and the approximate amount of 
future annual benefits of plan
participants covered by insurance
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contracts issued by the employer and 
related parties?
h. Any alternative amortization method used? 
[SFAS 106, pars. 53 or 60, and 74 (AC 
P40.148 or .155, and .169)]?
i. The amount of gain or loss recognized 
during the period for a settlement or 
curtailment and a description of the 
nature of the event(s)?
j. The cost of providing special or 
contractual termination benefits 
recognized during the period and a 
description of the nature of the event(s)? 
[SFAS 106, par. 74 (AC P40.169)]
2. If more than one defined benefit 
postretirement plan exists:
a. Have the disclosures been aggregated for 
all of an employer’s single-employer 
defined benefit postretirement plans or 
disaggregated in groups so as to provide 
the most useful information (except that 
the aggregate plan assets and the 
aggregate accumulated postretirement 
benefit obligation of the underfunded 
plans shall be separately disclosed)?
[SFAS 106, par. 77 (AC P40.172)]
b. Are plans that provide primarily 
postretirement healthcare benefits and 
plans that provide primarily other 
postretirement welfare benefits separately 
disclosed if the accumulated
postretirement benefit obligation of the 
latter plans is significant relative to 
the aggregate accumulated postretirement 
benefit obligation for all of the plans? 
[SFAS 106, par. 78 (AC P40.173)]
3. If there is a multiemployer plan, do 
disclosures include:
a. A description of the multiemployer plan(s) 
including the employee groups covered, the
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No N/A
Yes No N/A
type of benefits provided (defined benefit 
or defined contribution), and the nature 
and effect of significant matters 
affecting comparability of information for 
all periods presented?
b. The amount of postretirement benefit cost 
recognized during the period, if 
available. Otherwise, the amount of the 
aggregate required contribution for the 
period to the general health and welfare 
benefit plan that provides health and 
welfare benefits to both active employees 
and retirees?
[SFAS 106, par. 82 (AC P40.178)]
4. If there are one or more defined
contribution postretirement plans, have the 
following items been disclosed separately 
from defined benefit postretirement plan 
information:
a. A description of the plan(s) including 
employee groups covered, the basis for 
determining contributions, and the nature 
and effect of significant matters 
affecting comparability of information for 
all periods presented?
b. The amount of cost recognized during the 
period?
[SFAS 106, par. 106 (AC P40.198)]
J. Segment Information
1. If required, does the financial statement 
presentation include segment information? 
[SFASs 14 and 21 (AC S20); SFAS 24, pars.
4-5 (AC S20.109-.110); SFAS 30, par. 6 (AC 
S20.145); TBs 79-4 and 79-5 (AC S20.501- 
.504)]
K. Lessors
1. Are lessor disclosures appropriate and 
adequate?
[SFAS 13, pars. 23, 29 and 47, and SFAS 91, 
par. 25d (AC L10.119, .125 and .149)]
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L. Lessees
1. For capital leases do disclosures include:
a. Gross amounts of assets recorded by major 
classes as of the date of each balance
sheet presented? _____
b. Future minimum lease payments as of the
date of the latest balance sheet 
presented, in total and for each of the 
next five years, with separate deductions 
for executory costs and imputed interest 
to reduce net minimum lease payments to 
present value? _____
c. Total future minimum sublease rentals 
under noncancelable subleases as of the 
date of the latest balance sheet
presented? _____
d. Total contingent rentals actually incurred
for each period presented? _____
e. Assets recorded under capital leases and 
the related accumulated amortization, and 
obligations under those leases identified 
separately in the balance sheet or a note?
[SFAS 13, pars. 13 and 16 (AC L10.112a)] _____
2. For operating leases that have initial or 
remaining noncancelable lease terms in 
excess of one year, do disclosures include:
a. Future minimum rental payments required as 
of the latest balance sheet presented in
total and for each of the next five years? _____
b. Total future minimum rentals under 
noncancelable subleases as of the date of 
the latest balance sheet presented?
[SFAS 13, par. 16b (AC L10.112b)] _____
3. For all operating leases do disclosures 
include rental expense for each period 
presented, with separate amounts for minimum 
rentals, contingent rentals, and sublease 
rentals?
[SFAS 13, par. 16c (AC L10.112c)] _____
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4. Do disclosures include a general description 
of the lessee's leasing arrangements 
including but not limited to:
a. Bases for determination of contingent 
rentals?
b. Terms of any renewal or purchase options 
or escalation clauses?
c. Restrictive covenants?
[SFAS 13, par. 16d (AC L10.112d)]
M. Other Liabilities and Deferred Credits
1. If the entity is subject to income taxes:
a. Have deferred tax liabilities been 
classified as current or noncurrent based 
on the related asset or liability for 
financial reporting?
[SFAS 109, par. 41 (AC I27.140)]
b. Have deferred tax liabilities not related 
to an asset or liability for financial 
reporting been classified according to the 
expected reversal date of the temporary 
difference pursuant to SFAS 37?
[SFAS 109, par. 41 (AC I27.140)]
c. Have the following items been offset and 
presented as a single amount for a 
particular tax-paying component and within 
a particular tax-paying jurisdiction:
(1).  All current deferred tax liabilities and
assets?
(2).  All noncurrent deferred tax liabilities
and assets?
[SFAS 109, par. 42 (AC I27.141)]
d. Have the components of the total of all 
deferred tax liabilities recognized in the 
balance sheet been disclosed?
[SFAS 109, par. 43 (AC I27.142)]
e. Has the following information been
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disclosed whenever a deferred tax 
liability is not recognized because of the 
exceptions to comprehensive recognition of 
deferred taxes for any of the areas 
addressed by APB 23 (as amended by SFAS 
109):
(1).  A description of the types of temporary
differences for which a deferred tax 
liability has not been recognized and 
the types of events that would cause 
those temporary differences to become 
taxable?
(2).  The cumulative amount of each type of
temporary difference?
(3).  The amount of the unrecognized deferred
tax liability for temporary differences 
related to investments in foreign 
investees that is essentially permanent 
in duration if determination of that 
liability is practicable or a statement 
that the determination is not 
practicable?
(4).  The amount of the unrecognized deferred
tax liability for certain other 
temporary differences?
[SFAS 109, pars. 31-32 and 44 (AC 
I27.130-.131 and .143)]
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REPORTING CHECKLISTS
These checklists have been developed by the staff of the Technical 
Information Division of the AICPA as nonauthoritative practice aids. 
For an explanation of the references used in these checklists, see 
page 5 of this publication.
Yes No N/A
A. AUDIT REPORTS
1. Does the auditor’s report include appropriate:
a. Title that includes the word ’’independent”?
[SAS 58, par. 8 (AU 508.08)] _______________
b. Addressee?
[SAS 58, par. 9 (AU 508.09)] _______________
c. Date (or dual dates) of the report?
[SAS 1, sec. 530 (AU 530); SAS 26, pars. 15-17 
(AU 504.15-.17); SAS 58, par. 74
(AU 508.74)] _______________
2. If the accountant is not independent, regardless 
of the extent of services provided, has the 
appropriate disclaimer been expressed? [SAS 26, 
pars. 8-10 (AU 504.08-.10) or SSARS 1, pars. 22
and 38 (AR 100.22 and .38)] _______________
3. Does the reporting language conform with the 
auditor’s standard report on single-period or 
comparative financial statements, whichever 
applies?
[SAS 58, par. 8 (AU 508.08)] _______________
4. Does the report include appropriate language in 
respect of the following:
a. Report on only one basic financial statement and 
there are no scope limitations?
[SAS 58, pars. 47-48 (AU 508.47 -.48)] _______________
b. Report on comparative statements of revenues and 
expenses [statements of operations], fund 
balances [retained earnings], and cash flows of 
general funds [cash flow], without presentation 
of the comparative balance sheets for the prior 
years?
[SAS 58, par. 8, fn. 7 (AU 508.08, fn. 7)] _______________
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c. Part of the audit was made by other 
independent auditors, and the principal 
auditors are indicating a division of 
responsibility for the audit in their 
report?
[SAS 1, sec. 543 (AU 543); SAS 58, pars. 12-13 
(AU 508.12-.13), SAS 64, par. 3 (AU 543.16)]
d. Departure from a promulgated accounting 
principle when conformity would result in a 
misleading presentation?
[SAS 58, pars. 14-15 (AU 508.14 -.15)]
e. Updating of a previously issued report?
[SAS 58, par. 78 (AU 508.78)]
f. Comparative financial statements with differing 
opinions?
[SAS 58, pars. 74-76 (AU 508.74 -.76)]
g. Audited and unaudited financial statements in 
comparative form?
[SAS 26, pars. 14-17 (AU 504.14-.17)]
h. Decision to emphasize a matter?
[SAS 58, par. 37 (AU 508.37)]
5. Has explanatory language been added to the 
auditor’s report if:
a. The financial statements are affected by 
uncertainties concerning future events, the 
outcome of which is not susceptible of 
reasonable estimation at the date of the 
auditor's report?
[SAS 58, pars. 16-33 (AU 508.16-.33)]
b. The auditor concludes that there is substantial 
doubt about the provider's ability to continue 
as a going concern for a reasonable period of 
time and that conclusion is expressed through 
the use of the phrase, "substantial doubt about 
the provider's ability to continue as a going 
concern"?
[SAS 64, par. 1 (AU 341.12-.13)]
c. There has been a material change between periods 
in accounting principles or in the method of 
their application?
[SAS 58, pars. 34-36 (AU 508.34-.36)]
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d. In an updated report on comparative financial 
statements, the current opinion on the prior 
period is different from the one
previously expressed?
[SAS 58, pars. 77-78 and 81-83
(AU 508.77-.78 and .81-.83)] ____
e. Other information in a document containing 
audited financial statements is materially 
inconsistent with information appearing in the 
financial statements?
[SAS 8 (AU 550)] ____
f. The auditor wishes to emphasize a matter 
regarding the financial statements?
[SAS 58, par. 37 (AU 508.37)] ____
6. If the financial statements of a prior period have 
been audited by a predecessor auditor whose report 
is not presented, did the successor auditor 
indicate in the introductory paragraph:
a. The financial statements of the prior period
were audited by another auditor? ____
b. The date of the predecessor auditor’s report? ____
c. The type of report issued by the predecessor
auditor? ____
d. If the report was other than a standard report, 
the substantive reasons therefor?
[SAS 64, par. 2 (AU 508.83)]
7. If the financial statements have been restated 
does the introductory paragraph indicate that a 
predecessor auditor reported on the financial 
statements of the prior period before restatement? 
[SAS 64, par. 2 (AU 508.83)]
8. If the successor auditor was engaged to audit and 
applied sufficient procedures to satisfy himself 
or herself as to the appropriateness of the 
restatement adjustments, did he or she report on 
the adjustments?
[SAS 64, par. 2 (AU 508.83)]
9. If, following a pooling-of-interests transaction, 
an auditor is engaged to report on restated
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financial statements for one or more prior years 
when other auditors audited one or more of the 
entities included in such financial statements, 
did he or she include appropriate explanatory 
language?
[SAS 64, par. 3 (AU 543.16)]
10. Has a qualified opinion or disclaimer of opinion 
been expressed if scope limitations precluded 
application of one or more auditing procedures 
considered necessary in the circumstances?
[SAS 58, pars. 40-45 (AU 508.40-.45);
SAS 31, par. 23 (AU 326.23)]
11. Has a qualified opinion or adverse opinion been 
expressed because of a lack of conformity with 
GAAP (including inadequate disclosure)?
[SAS 32, par. 3 (AU 431.03); SAS 34, par. 11 (AU 
340.11); SAS 58, pars. 49-66
(AU 508.49-.66); SAS 54, par. 18 (AU 317.18)]
12. If a qualified opinion, adverse opinion or 
disclaimer of opinion is expressed, are all the 
substantive reasons for the opinion or disclaimer 
disclosed?
a. Is the reporting language clear and appropriate? 
[SAS 58, pars. 38-72 (AU 508.38 -.72)]
13. Does the report include modification, if 
applicable, for the following:
a. Conditions that precluded application of 
necessary auditing procedures to opening 
long-term investments?
[SAS 58, par. 42 (AU 508.42)]
b. Regulated companies?
[SAS 1, sec. 544.02 -.04 (AU 544.02 -.04); SAS 
62, pars. 2-10 (AU 623.02-.10)]
c. Client representations about related party 
transactions that are unsubstantiated by 
management?
[SAS 45, par. 12 (AU 334.12)]
d. Client’s refusal to provide written 
representations?
[SAS 19, par. 11 (AU 333.11)]
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e. Limitations on scope of lawyer’s response?
[SAS 12, pars. 12-14 (AU 337.12-.14)]
f. Unresolved matters involving specialists?
[SAS 11, par. 9 (AU 336.09)]
g. Financial statements materially affected by an 
irregularity?
[SAS 53, par. 26 (au 316. 26)]
h. Illegal acts by clients?
[SAS 54 (AU 317)]
i. Segment information?
[SAS 21 (AU 435)]
j. Material misstatement of the financial 
statements?
[SAS 47, par. 31 (AU 312.31)]
k. Financial statements issued before the effective 
date of a Statement of Financial Accounting 
Standards when disclosure is not made of the 
effect of a restatement which will be required 
in the future as a result of the Statement? 
[Interpretation 3 of SAS 1, section 410 (AU 
9410.13-.19)]
14. Has a piecemeal opinion been avoided?
[SAS 62, par. 14 (AU 623.14); SAS 58, 
par. 73 (AU 508.73)]
15. If information accompanies the basic financial 
statements in an auditor-submitted document:
a. Is there a clear distinction between the 
client’s representations and auditor's 
representations?
[SAS 29, par. 20 (AU 551.20)]
b. Does the auditor's report on the accompanying 
information:
(1).  State that the audit was made for the purpose
of forming an opinion on the basic financial 
statements taken as a whole?
(2).  Specifically identify the accompanying
information?
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(3).  State that the accompanying information is
presented for purposes of analysis and is not
part of the basic financial
statements?
(4).  State whether the additional information has
been subjected to the auditing procedures 
applied in auditing the basic financial 
statements and the appropriate expression of 
opinion or disclaimer?
[SAS 29, pars. 6-11 (AU 551.06 -.11)]
16. If an auditor-submitted document with accompanying 
information (long-form report) is coexisting with 
a document that includes just the basic financial 
statements and auditor’s report:
a. Do the basic financial statements in all 
coexisting documents consistently include all 
the information necessary for a fair 
presentation in conformity with GAAP?
[SAS 29, par. 21 (AU 551.21)]
b. Are any additional comments or 
explanations by the auditor consistent 
with the description of the scope of the 
audit in the auditor's standard (or modified) 
report?
[SAS 29, par. 20 (AU 551.20)]
17. If the document contains interim financial 
information, has the auditor’s report been 
expanded if required?
[SAS 71, pars. 30-34 (AU 722.30 -.34)]
18. If supplementary information required by the FASB 
is presented outside the basic financial 
statements in an auditor-submitted document, has 
an opinion been disclaimed on such information 
unless it has been audited?
[SAS 29, par. 7 (AU 551.07); SAS 27, pars. 8 and 
11 (AU 553.08 and .11)]
19. Reportable conditions in the internal 
control structure must be communicated, 
preferably in writing, to the audit committee 
or to individuals with equivalent 
responsibility and authority [SAS 60, pars.
1-2 (AU 325.01 -.02)]. If a report on
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internal accounting control is to be issued, 
is the appropriate form used for:
a. Expression of an opinion on the entity’s system 
of internal accounting control in effect as of a 
specified date or during a specific period of 
time?
[SAS 30, pars. 37-46 (AU 642.37 -.46)] ____
b. Reporting on significant deficiencies or other 
appropriate matters regarding the internal 
control structure that were noted during an 
audit?
[SAS 60 (AU 325.04-.06)] ____
c. Reports for restricted use of management and 
specified regulatory agencies, based on the 
regulatory agencies’ pre-established criteria?
[SAS 30, pars. 54-59 (AU 642.54 -.59)] ____
d. Other special purpose reports on all or part of 
an existing or proposed system for 
restricted use of management or specified third 
parties?
[SAS 30, pars. 60-61 (AU 642.60 -.61) SAS 44,
pars. 35, 41 and 46 (AU 324.35, .41, and .46)] ____
20. If reporting in a client-prepared document on 
condensed financial statements (either for an 
annual or an interim period) that are derived from 
audited financial statements of a public entity 
that is required to file, at least annually, 
complete audited financial statements with a 
regulatory agency, does the auditor’s report 
indicate:
a. That an audit was performed and an opinion 
expressed on the complete financial
statements? ____
b. The date of the report on the complete financial 
statements?
c. The type of opinion expressed?
d. Whether, in the auditor's opinion, the 
information set forth in the condensed 
financial statements is fairly stated in 
all material respects in relation to the
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complete financial statements from which 
it has been derived?
[SAS 42, par. 5 (AU 552.05)] ____
21. If a statement that names the auditor, and states 
that condensed financial statements have been 
derived from audited financial statements, is made 
in a client-prepared document that does not 
include complete audited financial statements, and 
the client is not a public entity that is required 
to file complete audited financial statements with 
a regulatory agency at least annually, does the 
auditor•s report express an adverse opinion on the 
condensed financial statements because of 
inadequate disclosure?
[SAS 42, par. 7, fn. 6 (AU 552.07, fn. 6); SAS 58, 
pars. 55-58 (AU 508.55-.58)] ____
22. If reporting on selected financial data that are 
included in a client-prepared document that 
contains audited financial statements (or, with 
respect to a public entity, that incorporates such 
statements by reference to information filed with 
a regulatory agency) and that are derived from 
audited financial statements, does the auditor’s 
report indicate the following:
a. That they have audited and expressed an opinion
on the complete financial statements? ____
b. The type of opinion expressed? ____
c. The specific data on which they are reporting? ____
d. Whether, in their opinion, the information 
set forth in the selected financial data is 
fairly stated in all material respects in 
relation to the complete financial statements
from which it has been derived? ____
23. If the selected financial data for any of the 
years presented are derived from financial 
statements that were audited by another 
independent auditor, does the auditor’s report on 
the selected financial data state that fact and 
express a disclaimer of opinion on that data?
[SAS 42, par. 9 (AU 552.09)]
B. COMPILATION AND REVIEW REPORTS
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1. For compiled financial statements, does the report 
state that:
a. A compilation has been performed in accordance 
with Statements on Standards for Accounting and 
Review Services issued by the American Institute 
of Certified Public Accountants?
[SSARS 7, par. 5]
b. A compilation is limited to presenting in the 
form of financial statements information that is 
the representation of management (owners)?
[See SSARS 3, par. 3 (AR 300.03) for different 
wording that may be used when the financial 
statements are included in a prescribed form and 
the form or related instructions call for 
departures from generally accepted accounting 
principles.]
c. The financial statements have not been audited 
or reviewed and, accordingly, the accountant 
does not express an opinion or any other form of 
assurance on them?
[SSARS 1, par. 14 (AR 100.14); SSARS 5, par. 1 
(AR 500.01)]
2. For reviewed financial statements, does the report 
state that:
a. A review was performed in accordance with 
Statements on Standards for Accounting and 
Review Services issued by the American Institute 
of Certified Public Accountants?
[SSARS 7, par. 5]
b. All information included in the financial 
statements is the representation of the 
management (owners) of the provider?
c. A review consists principally of inquiries of 
organization personnel and analytical procedures 
applied to financial data?
d. A review is substantially less in scope than an 
audit, the objective of which is the expression 
of an opinion regarding the financial statements 
taken as a whole and, accordingly, no such 
opinion is expressed?
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e. The accountant is not aware of any material 
modifications that should be made to the 
financial statements in order for them to be in 
conformity with GAAP or, where applicable, with 
an other comprehensive basis of accounting, 
other than those modifications, if any, 
indicated in the report?
[SSARS 1, par. 32 (AR 100.32)]
3. For compiled and reviewed financial statements, 
does the report exclude a description of any other 
procedures that the accountant might have 
performed before or during the engagement?
[SSARS 1, pars. 14 and 32 (AR 100.14 and .32)]
4. If compiled financial statements omit substan­
tially all disclosures required by GAAP, does the 
accountant’s report clearly indicate such 
omission?
[SSARS 1, pars. 19 and 21 (AR 100.19 
and .21)]
5. If compiled financial statements include 
disclosures about only a few matters, are such 
disclosures labeled "Selected Information— 
Substantially All Disclosures Required by 
Generally Accepted Accounting Principles Are Not 
Included"?
[SSARS 1, par. 19 (AR 100.19)]
6. If the financial statements are presented on a 
basis of accounting other than GAAP, and the basis 
of accounting is not disclosed, does the
accountant’s report disclose the basis of 
accounting?
[SSARS 1, par. 20 (AR 100.20)]
7. If the financial statements contain a departure 
from GAAP or, where applicable, an other 
comprehensive basis of accounting, does the 
accountant’s report disclose the departure?
[SSARS 1, par. 39 (AR 100.39)]
a. If the effects of the departure on the
financial statements have been determined 
by management or are known as a result of 
the accountant's procedures, are these 
effects also disclosed in the modified report?
or
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b. If the effects of the departure on the financial 
statements have not been determined, has the 
accountant’s report been modified to state this? ____
8. If the accountant is not independent with respect 
to the provider for which financial statements 
have been compiled, does the compilation report 
state in the last paragraph, "We are (I am) not 
independent with respect to XYZ Company"?
(Accountants are precluded from issuing a review 
report if they are not independent.)
[SSARS 1, pars. 22 and 38 (AR 100.22
and .38)] ____
9. Is the report dated? ____
10. Does each page of the financial statements include 
a reference such as "See Accountant's Compilation 
(Review) Report"?
[SSARS 1, pars. 16 and 34 (AR 100.16 and .34];
SSARS 2, par. 6 (AR 200.06)] ____
11. When accompanying information is presented with 
the financial statements, does the accountant's 
report indicate degree of responsibility with 
respect to such information?
{SSARS 1, par. 43 (AR 100.43)] ____
12. If an audit engagement has been changed to a 
review or compilation, does the report omit 
reference to; a) the original engagement, b) any 
auditing procedures that may have been performed, 
and c) any scope limitation that resulted in the 
changed engagement?
[SSARS 1, par. 49 (AR 100.49)] ____
13. For comparative financial statements:
a. Does the accountant's report cover each period 
presented?
[SSARS 2, par. 2 (AR 200.02)] ____
b. If compiled financial statements that omit 
substantially all of the disclosures required by 
GAAP are presented with the comparative 
financial statements, do all the periods 
presented also omit such disclosures, and does 
the accountant's compilation report include an 
additional paragraph that indicates:
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(1).  The nature of the previous service rendered
(compilation, review or audit)? ____
(2).  Date of the previous reports? ____
(3).  Appropriate language in accordance with SSARS
No. 1, paragraphs 19-20 and SSARS 2, paragraph 
30?
[SSARS 1, pars. 19-21 (AR 100.19-.21);
SSARS 2, pars. 5 and 29-30 (AR 200.05 and
.29-.30)] ____
c. If the level of service performed by the 
continuing accountant on the current-period 
financial statements is the same or higher than 
that performed on the financial statements of 
the prior period presented, has the continuing 
accountant's report on the prior period been 
updated?
[SSARS 2, pars. 8-10 (AR 200.08 -.10)] ____
d. If the level of service performed by the 
continuing accountant on the current-period 
financial statements is lower than that 
performed on the financial statements of the 
prior period presented:
(1).  Does the report on the current period include
a separate paragraph that describes the 
responsibility assumed for the prior period? ____
(2.  Is the report on the current period
accompanied by or combined with a reissued 
report on the financial statements of the 
prior period presented?
[SSARS 2, pars. 8, 11 and 12 (AR 200.08 and 
.11-.12)] ____
e. If the report requires a changed reference to a 
departure from GAAP regarding the prior period 
presented, does the explanatory paragraph in the 
report include:
(1).  The date of the previous report? ____
(2).  Description of the circumstances or events
underlying the change? ____
(3).  Indication that the prior-period financial
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statements have changed?
[SSARS 2, pars. 14-15 (AR 200.14 -.15)]
f. If the predecessor accountant does not 
reissue his or her compilation or review report 
on the prior-period financial statements, has 
the successor accountant made appropriate 
reference in his or her report to the
predecessor’s report, or performed a 
compilation, review, or audit of the statements 
of the prior period and reported on them 
accordingly?
[SSARS 2, pars. 16-19 (AR 200.16 -.19)]
g. If the prior-period financial statements 
presented have been changed, has the 
predecessor or successor accountant reported 
on them as presented?
[SSARS 2, pars. 25-26 (AR 200.25 -.26)]
h. If the current-period financial statements were 
compiled or reviewed and the prior period was 
audited, and the audit report has not been 
reissued, does the current-period report include 
a separate paragraph that contains the 
following:
(1).  Statement that the prior-period financial
statements were previously audited?
(2).  Date of the previous report?
(3).  Type of opinion previously expressed?
(4).  If the opinion was other than unqualified, the
substantive reasons therefor?
(5).  That no auditing procedures were performed
after the date of the previous report? [For 
guidance on situations when the current period 
is audited and the prior period is compiled or 
reviewed, see Statement on Auditing Standards 
No. 26 (AU 504)]
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Checklist for Auditors' Reports on Audits Performed Under 
Government Auditing Standards and Under OMB Circular A-1331
This checklist has been developed by the staff of the Technical 
Information Division of the AICPA as a nonauthoritative practice 
aid.
This checklist has two parts: Part I is for reports on audits 
performed under Government Auditing Standards ("Yellow Book"). 
Part II is for reports on audits performed under the Single Audit 
Act in accordance with OMB Circular A-133. For audits performed 
under Circular A-133, both Parts I and II of this checklist must be 
completed.
Explanation of References:
A-133 = Office of Management and Budget (OMB) Circular A-133 
GAS = Government Auditing Standards ("Yellow Book", issued
by GAO, 1988 Revision)
SAS = Statement on Auditing Standards
AU = Reference to section number in AICPA Professional 
Standards (vol. 1) of SAS cited
SOP 92-9 = AICPA Statement of Position, Audits of Not-for-profit 
Organizations Receiving Federal Awards
1 On March 8, 1990, The Office of Management and Budget issued 
Circular A-133, Audits of Institutions of Higher Education and 
Other Nonprofit Institutions, to implement a "single audit" re­
quirement for nonprofit institutions. Circular A-133 requires that 
the auditor perform the audit in accordance with Government 
Auditing Standards (the "Yellow Book") issued by the Comptroller 
General of the United States.
Circular A-133, which supersedes the audit provisions of Circular 
A-110, is effective for audits of fiscal years beginning on or 
after January 1, 1990. Because Circular A-133 permits biennial 
audits, some institutions may not be required to follow its 
requirements until the audits of their financial statements for the 
fiscal year ending June 30, 1992.
SAS No. 68, Compliance Auditing Applicable to Governmental Entities 
and Other Recipients of Governmental Financial Assistance, provides 
guidance on planning, performing, and reporting on the compliance 
aspects of audits in accordance with GAAS, GAO Standards, Circular 
A-133, and Circular A-128, which applies to State and Local 
Governmental entities.
On December 28, 1992 the AICPA issued SOP 92-9, Audits of Not-for- 
Profit Organizations Receiving Federal Awards, to provide guidance 
on the auditor's responsibilities when conducting an audit in ac­
cordance with Circular A-133. It incorporates the guidance in SAS
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Footnote 1 (continued)
68, SOP 92-7, OMB's October 1991 Compliance Supplement for Audits 
of Institutions of Higher Learning and Other Non-Profit Institu­
tions, and the President's Council on Integrity and Efficiency 
Standards Subcommittee's Position Statement No. 6 [A-133 Questions 
and Answers].
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CHECKLIST QUESTIONNAIRE
Part I - REPORTS ON AUDITS PERFORMED IN ACCORDANCE
WITH GOVERNMENT AUDITING STANDARDS (THE "YELLOW
BOOK")
1. In an audit performed in accordance with The
Yellow Book, were the following reports issued?
a. A report on the provider's basic financial 
statements:1
b. A report on internal control structure:
c. A report on compliance with laws and regula­
tions that may have a direct and material 
effect on the basic financial statements?
1 See checklist for auditor's reports on the basic financial 
statements beginning on page 59.
2 Under the Yellow Book, a report on the internal control 
structure is required in all audits, even if no reportable 
conditions were noted. [SAS 68, par. 33 (AU 801.33)]
[SOP 92-9, par. 7.2]
2. Does each auditor's report listed in step No. 1 
that the audit was conducted in accordance with 
generally accepted auditing standards and The 
Yellow Book?
[GAS, Ch. 5, par. 3; SOP 92-9, par. 7.4]
Report on Internal Control Structure2
3. Does the report on internal control structure 
include, at a minimum:
a. The scope of the auditor's work to obtain an 
understanding of the internal control 
structure, and to assess control risk?
b. The significant internal controls estab­
lished to ensure compliance with laws and 
regulations that have a material impact on 
the financial statements?
c. Any reportable conditions, including sepa­
rate identification of material weaknesses, 
identified as a result of the auditor's work 
in understanding and assessing the control 
risk?
d. A statement that the report is intended for 
the information of the audit committee,
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management, and specific legislative or 
regulatory bodies, but that this restriction 
is not intended to limit the distribution of 
the report, if a matter of public record?
[GAS, Ch. 5, pars. 17 and 18; SAS 68, pars. 33 
and 40 (AU 801.33 and .40)]
4. If the auditor has noted reportable conditions 
in the financial statement audit, does the audi­
tor's report on the internal control structure 
also contain:
a. The definition of reportable conditions?
b. A description of the reportable conditions 
noted?
c. The definition of material weakness?
d. If applicable, a statement that other 
matters involving the internal controls 
structure and its operation were communi­
cated to management in a separate letter?
[SAS 68, par. 40 (AU 801.40)]
5. If material weaknesses were noted in the report, 
did the auditor disclose the condition, cause, 
criteria, and effect of those material weak­
nesses?
[GAS, Chap. 5, par. 9, footnote 7]
6. If the auditor determined that deficiencies in 
the internal control structure are not signifi­
cant enough to be considered reportable condi­
tions (referred to as "nonreportable condi­
tions"), have those matters been communicated to 
the provider in writing (or orally, with working 
paper documentation)?
[SAS 68, par. 39 (AU 801.39); GAS Chap. 5, par. 
25]
7. If the auditor issues a separate written 
communication describing nonreportable 
conditions, does the auditor's report on the 
internal control structure refer to that 
separate communication?
[SAS 68, pars. 38 and 39 (AU 801.38-.39); SOP 
92-9, par. 7.12]
8. If no reportable conditions were noted during 
the audit, does the report disclose that no 
material weaknesses were identified?
[SAS 68, par. 42 (AU 801.42), SOP 92-9, par. 
7.11]
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Yes No N/A
Report on Compliance With Laws and Regulations
9. Does the report on compliance with laws and 
regulations conform to the standard report 
illustrated in SAS 68, par. 25 (AU 801.25)?
10. If the auditor decided not to test compliance 
with laws and regulations, does the report 
contain a statement that compliance with laws 
and regulations was not tested?
[SAS 68, par. 26 (AU 801.26) GAS, Chap. 5, par. 
6]
11. If the auditing procedures disclosed material 
instances of noncompliance, was the report on 
compliance appropriately modified?
[SAS 68, par. 27 (AU 801.27)]
a. Does that modified report include:
(1) The definition and identification of 
material instances of noncompliance 
noted?
(2) statement that the noncompliance noted 
was considered in forming an opinion on 
whether the provider's financial state­
ments are presented fairly, in conformity 
with generally accepted accounting 
principles?
[SAS 68, par. 27 (AU 801.27)]
12. If the report contains material instances of 
noncompliance, was a statement considered about:
a. Whether the misstatements have been cor­
rected?
or
b. The effect of such misstatements on the 
auditor's report on the basic financial 
statements?
[SAS 68, par. 28 (AU 801.28)]
13. Are immaterial instances of noncompliance 
reported in a separate communication to the 
provider?3
[SAS 68, pars. 29 and 95 (AU 801.29 and .95) 
GAS, Chap. 5, par. 8]
3 If there are no immaterial instances of noncompliance, the 
auditor may so note in the report. [SOP 92-9, par. 7.24]
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Yes
14. If the auditor issued a separate letter describ­
ing immaterial instances of noncompliance, did 
the compliance report include a reference to 
that letter?
[SAS 68, pars. 29 and 30 (AU 801.29 and .30), 
SOP 92-9, par. 7.16]
15. If the auditor became aware of illegal acts that 
could result in criminal prosecution, have they 
been communicated in a separate report to 
management?
[SAS 68, par. 31 (AU 801.31); GAS Chap. 5, par. 
5]
16. If the auditor became aware of illegal acts and 
remains uncertain about whether they will mater­
ially affect the financial statements, was the 
report qualified or a disclaimer of opinion 
issued?
[SOP 92-9, par. 7.18]
Other Matters
17. If performance audits are required by contract­
ual obligations, were findings presented in 
accordance with the guidance in The Yellow 
Book??
[GAS, Ch. 2, pars. 6-10]
18. If the auditor is unable to follow an applicable 
standard and is unable to withdraw from the en­
gagement, did the auditor disclose in the scope 
section of the report the fact that an appli­
cable standard was not followed, the reasons 
therefor, and the known effect of not following 
the standard on the results of the audit?
[GAS, Ch. 3, par. 27]
19. Does the auditor's report disclose the status of 
known but uncorrected significant or material 
findings and recommendations from prior audits 
that could have an effect on the current audit 
objective?
[SAS 68, par. 20, footnote 10 (AU 801.20); GAS, 
Ch. 3, par. 41, SOP 92-9, par. 7.41]
20. Does the auditor's report disclose in the scope 
section of the report audit scope impairments 
and the known effect they have on the results of 
the audit?
[GAS, Ch. 3, par. 42]
21. Did the auditor consider the impact on his or 
her report of the effects of noncompliance
77
No N/A
Yes No N/A
findings from other simultaneous audits that may 
result in claims for refunds?
[SOP 92-9, par. 7.43; See also SFAS 5 (AC C59)]
22. Do the reports on the schedule of federal 
awards, compliance, and internal control 
structure carry the same date as the report on 
the basic financial statements?
[SOP 92-9, par. 7.27]
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Yes No N/A
Part II - REPORTS ON AUDITS PERFORMED UNDER OMB
CIRCULAR A-133
1. If the provider is subject to the requirements 
of Circular A-133, are the following additional 
reports issued?
a. A report on a supplementary schedule of the 
provider's federal awards?4
b. A report on the internal control policies 
and procedures used to administer federal 
awards?
c. A report on compliance with specific laws 
and regulations that may have a direct and 
material effect on each major program.
d. A report on compliance with certain laws and 
regulations applicable to nonmajor pro­
grams.5
e. A report on compliance with general 
requirements.6
4 Under Circular A-133, a recipient or subrecipient of an award 
is required to prepare a schedule of federal awards. A sample 
schedule is presented in the Illustrative Financial Statements 
section of these checklists. [Attachment to Circular A-133, par. 
15(c)(1), SOP 92-9, pars. 4.7 and 7.20]
5 Under the Yellow Book, a report on the internal control 
structure is required in all audits even if no reportable 
conditions were noted. [SAS 68, par. 33 (AU 801.33)]
6 A report on compliance with general requirements is required 
regardless of whether there are any major programs. [SOP 92-9, 
par. 7.25]
[SOP 92-9, par. 7.19]
2 Does each auditor's report in step No. 1 contain 
a statement that the audit was conducted in 
accordance with generally accepted auditing 
standards; Government Auditing Standards, issued 
by the Comptroller General of the United States; 
and Office of Management and Budget (OMB) 
Circular A-133?
[SOP 92-9, Appendix D, Exhibits D-8 through 
D-18]
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Yes No N/A
3. Does the auditor's report on the provider's 
schedule of federal awards:
a. Identify major programs?
b. Show total expenditures for each program? 
[A-133, item 15c(1)]
Report on Internal Control Structure
4. Does the report on internal control structure 
include:
a. A description of the scope of the auditor's 
work to test the internal control structure 
policies and procedures?
b. A description of the provider's significant 
control policies and procedures established 
to provide reasonable assurance that it is 
managing its federal awards in compliance 
with applicable laws and regulations?
[SOP 92-9, par. 7.22]
5. If the auditor determines that tests of controls 
are likely to be ineffective in preventing or 
detecting noncompliance, is that matter dis­
closed as a "reportable condition?"
[SOP 92-9, par. 7.23]
6. If the auditor has limited his or her consid­
eration of the internal control structure for 
any reason, were the circumstances disclosed in 
the report on the internal control structure? 
[SOP 92-9, par. 7.23]
Report on Compliance with Specific Requirements 
Related to Major Programs
7. For audits of major programs, does the report on 
compliance with specific requirements conform to 
the standard report illustrated in SAS 68, par. 
81 (AU 801.81)?
8. If the auditor is disclaiming an opinion due to 
a scope limitation:
a. Were the reasons indicated, in a separate 
paragraph, why the audit did not comply with 
generally accepted auditing standards, 
Government Auditing Standards, or OMB 
Circular A-133?
b. Did the auditor state that the scope of the 
audit was not sufficient to warrant the ex­
pression of an opinion?
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Yes No N/A
c. Did the auditor disclose any reservations he 
or she had regarding compliance with appli­
cable laws and regulations? ___
[SAS 68, pars. 82 and 84 (AU 801.82 and .84)]
9. If the auditor expresses a qualified or adverse 
opinion due to material noncompliance on a major 
federal program, did the auditor state the basis
for such an opinion in the report? ___
[SAS 68, par. 85 (AU 801.85)]
10. If the auditing procedures disclosed instances
of noncompliance on major programs: ___
a. Did the resulting modification to the audi­
tor's report on compliance consider factors 
that include:
1. The number and types of instances of
noncompliance; ___
2. Determinability of questioned costs; and ___
3. Materiality of questioned costs. ___
b. If, after considering those factors, the
auditor concluded that the instances of 
noncompliance had a material effect on a 
federal program, was a qualified or adverse 
opinion issued? ___
or
c. If after considering those factors, the
auditor was unable to determine if the 
instance of noncompliance could have a 
material effect on the program, does the 
report state noncompliance occurred but the 
effect on the programs presently cannot be 
determined? ___
d. Is the effect of uncertainties associated 
with federal programs on the basic financial 
statements considered, and if necessary, was
the report modified? ___
[SOP 92-9; par. 7.24]
11. If the auditor was unable to examine appropriate
evidence to support the comply/noncomply decis­
ion, was the report appropriately modified? ___
[SOP 92-9, par. 7.24]
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Yes No N/A
Report on Compliance with General Requirements
12. Does the report on compliance with general re­
quirements conform to the standard report 
illustrated in SAS 68, par. 52 (AU 801.52)?
Report on Compliance Related to Nonmajor Programs
13. For nonmajor programs, does the report on com­
pliance conform to the standard report 
illustrated in SAS 68, par. 90 (AU 801.90)?
General
14. Does the auditor's report on compliance with 
laws and regulations include, for each federal 
award:
a. An identification of total amounts ques­
tioned as a result of noncompliance?
b. Any corrective action recommended by the 
auditor?
[SOP 92-9, pars. 7.30 and 7.32]
15. Were any immaterial findings included either (1) 
in a schedule of findings and costs, or (2) in a 
separate communication to management?
[SOP 92-9, par. 7.30]
16. If the audit is biennial, are both years within 
the period covered?
[SOP 92-9, par. 2.47]
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SAMPLE HOSPITAL
Statements of Revenue and Expenses of General Funds
Years Ended December 31, 19X7 and 19X6
See accompanying notes to financial statements.
19X7 19X6
Net patient service revenue (notes 3, 7 and 15) $92,656,000 $88,942,000
Other revenue 6,010,000 5,380,000
Total revenue 98,666,000 94,322,000
Expenses (notes 7, 8, 12, and 13)
Professional care of patients 53,016,000 48,342,000
Dietary services 4,407,000 4,087,000
General services 10,888,000 9,973,000
Administrative services 11,075,000 10,145,000
Employee health and welfare 10,000,000 9,335,000
Medical malpractice costs 1,125,000 200,000
Depreciation and amortization of property and equipment 4,782,000 4,280,000
Interest 1,752,000 1,825,000
Provision for bad debts 1,010,000 1,103,000
Total expenses 98,055,000 89,290,000
Income from operations 611,000 5,032,000
Nonoperating gains (losses)
Unrestricted gifts and bequests (note 10) 822,000 926,000
Loss on investment in affiliated company (note 4) (37,000) (16,000)
Income on investments of endowment funds 750,000 650,000
Income on investments whose use is limited
By board for capital improvements 1,120,000 1,050,000
By agreements with third-party payors for funded depreciation 850,000 675,000
Under indenture agreement 100,000 90,000
Other investment income 284,000 226,000
Nonoperating gains, net 3,889,000 3,601,000
Revenue and gains in excess of expenses and losses $ 4,500,000 $ 8,633,000
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SAMPLE HOSPITAL
Statements of Cash Flows of General Funds (Direct Method)*
Years Ended December 31, 19X7 and 19X6
19X7 19X6
Cash flows from operating activities and gains and losses 
Cash received from patients and third-party payors 
Cash paid to employees and suppliers
Other receipts from operations
Receipts from unrestricted gifts and bequests
Interest and dividends received
Interest paid (net of amount capitalized)
Net cash provided by operating activities and gains and losses
Cash flows from investing activities 
Purchase of property and equipment
Transfer from donor-restricted fund for purchase of property 
and equipment
Investment in affiliated company
Transfer to Sample Health System
Cash invested in assets whose use is limited
$ 90,342,000
(89,214,000)
6,042,000
1,122,000
2,510,000
(1,780,000)
9,022,000
(4,728,000)
243,000
(394,000)
(4,798,000)
$ 85,619,000
(81,510,000)
5,563,000
905,000
2,330,000
(1,856,000)
11,051,000
(5,012,000)
255,000
(425,000)
(1,000,000)
(855,000)
Net cash used by investing activities
Cash flows from financing activities 
Increase in retainage and construction accounts payable 
Repayment of long-term debt
Payments from donor-restricted funds related to temporary loans 
Payments on capital lease obligations 
Temporary loans from (to) donor-restricted funds
Net cash used by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
(9,677,000)
183,000
(1,200,000)
500,000
(550,000)
300,000
(767,000)
(1,422,000)
4,525,000
$ 3,103,000
(7,037,000)
175,000
(1,630,000)
(600,000)
(193,000)
(2,248,000)
1,766,000
2,759,000
$ 4,525,000
See accompanying notes to financial statements.
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. 
The indirect method is presented on page 94.
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Reconciliation of Revenue and Gains in Excess of Expenses and Losses 
to Net Cash Provided by Operating Activities and Gains and Losses
Revenue and gains in excess of expenses and losses
Adjustments to reconcile revenue and gains in excess of expenses 
and losses to net cash provided by operating activities and gains and losses
$4,500,000 $ 8,633,000
Depreciation and amortization of property and equipment 4,782,000 4,280,000
Provision for bad debts 1,010,000 1,103,000
Amortization of deferred financing costs 66,000 45,000
Loss on investment in affiliated company 53,000 —
Noncash gifts and bequests — (175,000)
Decrease in amounts due to third-party payors (398,000) (77,000)
Increase in liability for estimated malpractice costs 1,125,000 200,000
Increase in patient accounts receivable (1,916,000) (3,141,000)
Increase in supplies and other current assets (193,000) (118,000)
Increase in accounts payable and accrued expenses 303,000 301,000
Increase in interest earned but not received on assets whose use is limited (310,000) —
Net cash provided by operating activities and gains and losses $ 9,022,000 $11,051,000
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
See accompanying notes to financial statements.
91
SAMPLE HOSPITAL
Statements of Cash Flows of General Funds (Indirect Method)*
Years Ended December 31, 19X7 and 19X6
Supplemental Disclosures of Cash Flow Information
Sample Hospital entered into capital lease obligations of $600,000 for new equipment in 19X7.
Cash paid for interest (net of amount capitalized) in 19X7 and 19X6 was $1,780,000 and $1,856,000, respectively. 
See accompanying notes to financial statements.
19X7 19X6
Cash flows from operating activities and gains and losses
Revenue and gains in excess of expenses and losses $ 4,500,000 $ 8,633,000
Adjustments to reconcile revenue and gains in excess of expenses and 
losses to net cash provided by operating activities and gains and losses
Depreciation and amortization of property and equipment 4,782,000 4,280,000
Provision for bad debts 1,010,000 1,103,000
Amortization of deferred financing costs 66,000 45,000
Loss on investment in affiliated company 53,000 —
Noncash gifts and bequests — (175,000)
Decrease in net amounts due to third-party payors (398,000) (77,000)
Increase in liability for estimated malpractice costs 1,125,000 200,000
Increase in patient accounts receivable (1,916,000) (3,141,000)
Increase in supplies and other current assets (193,000) (118,000)
Increase in accounts payable and accrued expenses 303,000 301,000
Increase in interest earned but not received on assets whose use is limited (310,000) —
Net cash provided by operating activities and gains and losses 9,022,000 11,051,000
Cash flows from investing activities
Purchase of property and equipment (4,728,000) (5,012,000)
Transfer from donor-restricted fund for purchase of property
and equipment 243,000 255,000
Investment in affiliated company (394,000) (425,000)
Transfer to Sample Health System — (1,000,000)
Cash invested in assets whose use is limited (4,798,000) (855,000)
Net cash used by investing activities (9,677,000) (7,037,000)
Cash flows from financing activities
Increase in retainage and construction accounts payable 183,000 175,000
Repayment of long-term debt (1,200,000) (1,630,000)
Payments from donor-restricted funds related to temporary loans 500,000 —
Payments on capital lease obligation (550,000) (600,000)
Temporary loans from (to) donor-restricted funds 300,000 (193,000)
Net cash used by financing activities (767,000) (2,248,000)
Net increase (decrease) in cash and cash equivalents (1,422,000) 1,766,000
Cash and cash equivalents at beginning of year 4,525,000 2,759,000
Cash and cash equivalents at end of year $ 3,103,000 $ 4,525,000
* The direct and indirect methods of reporting cash flows by hospitals are presented for illustrative purposes. 
The direct method is presented on pages 92 and 93.
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SAMPLE HOSPITAL
Notes to Financial Statements
December 31, 19X7 and 19X6
1. Summary of Significant Accounting Policies
Organization
Sample Hospital (Hospital) is a not-for-profit acute care hospital. Effective June 30, 19X6, under a plan of reorganiza­
tion, Sample Health System was formed as the parent holding company of the Hospital. In its capacity as sole 
member of the Hospital, Sample Health System has the right to appoint Hospital trustees, approve major Hospital 
expenditures, and approve long-term Hospital borrowings.
Charity care
The Hospital provides care to patients who meet certain criteria under its charity care policy without charge or at 
amounts less than its established rates. Because the Hospital does not pursue collection of amounts determined to 
qualify as charity care, they are not reported as revenue.
Income taxes
The Hospital is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is 
exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Net patient service revenue
Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, 
and others for services rendered, including estimated retroactive adjustments under reimbursement agreements 
with third-party payors. Retroactive adjustments are accrued on an estimated basis in the period the related services 
are rendered and adjusted in future periods as final settlements are determined.
Investments and investment income
Donated investments are reported at fair value at the date of receipt, which is then treated as cost. Marketable equity 
securities included in investment portfolios are carried at the lower of aggregate cost (determined on an average-cost 
basis) or market at the balance sheet date. Other marketable securities are stated at cost, adjusted for impairments 
in value that are deemed to be other than temporary. Sample Hospital's investment in Affiliated Company is 
reported on the equity method of accounting that approximates Sample Hospital's equity in the underlying net 
assets of Affiliated Company.
Investment income on proceeds of borrowings that are held by a trustee, to the extent not capitalized, and invest­
ment income on assets deposited in the malpractice trust are reported as other revenue. Investment income from 
all other general fund investments and investment income of endowment funds are reported as nonoperating 
gains. Investment income and gains (losses) on investments of donor-restricted funds are added to (deducted from) 
the appropriate restricted fund balance.
Pledges
Pledges, less an allowance for uncollectible amounts, are recorded as receivables in the year made. Unrestricted 
pledges are reported in the statement of revenue and expenses of general funds; restricted pledges are reported as 
additions to the appropriate restricted fund balance.
Statement of revenue and expenses of general funds
For purposes of display, transactions deemed by management to be ongoing, major, or central to the provision of 
health care services are reported as revenues and expenses. Peripheral or incidental transactions are reported as 
gains and losses.
Costs of borrowing
Interest cost incurred on borrowed funds during the period of construction of capital assets is capitalized as a 
component of the cost of acquiring those assets.
Deferred financing costs are amortized over the period the obligation is outstanding using the interest method.
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Amortization of deferred financing costs is capitalized during the period of construction of capital assets. 
Donor-restricted funds
Donor-restricted funds are used to differentiate resources, the use of which is restricted by donors or grantors, from 
resources of general funds on which donors or grantors place no restriction or that arise as a result of the operations 
of the Hospital for its stated purposes. Restricted gifts and other restricted resources are recorded as additions to 
the appropriate restricted fund.
Resources restricted by donors for plant replacement and expansion are added to the general fund balance to the 
extent expended within the period.
Resources restricted by donors or grantors for specific operating purposes are reported in other operating revenue 
to the extent used within the period.
Assets whose use is limited
Assets whose use is limited include assets set aside by the Board of Trustees for future capital improvements, over 
which the Board retains control and may at its discretion subsequently use for other purposes; assets set aside in 
accordance with agreements with third-party payors; and assets held by trustees under indenture agreements and 
self-insurance trust arrangements.
Property and equipment
Property and equipment acquisitions are recorded at cost. Property and equipment donated for hospital operations 
are recorded as additions to the donor-restricted plant replacement and expansion funds at fair value at the date of 
receipt and as transfers to the general fund balance when the assets are placed in service.
Depreciation is provided over the estimated useful life of each class of depreciable asset and is computed on the 
straight-line method. Equipment under capital leases is amortized on the straight-line method over the shorter 
period of the lease term or the estimated useful life of the equipment. Such amortization is included in depreciation 
and amortization in the financial statements.
An accelerated method for depreciating certain operating equipment acquired before 1970 has been elected for 
third-party reimbursement purposes. Third-party reimbursement is deferred to the extent of the effect of the differ­
ence between accelerated depreciation used for reimbursement reporting and straight-line depreciation used for 
financial reporting.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months 
or less, excluding amounts whose use is limited by board designation or other arrangements under trust agree­
ments or with third-party payors.
Estimated malpractice costs
The provision for estimated self-insured medical malpractice claims includes estimates of the ultimate costs for both 
reported claims and claims incurred but not reported.
2. Charity Care
The Hospital maintains records to identify and monitor the level of charity care it provides. These records include 
the amount of charges foregone for services and supplies furnished under its charity care policy, the estimated cost 
of those services and supplies, and equivalent service statistics. The following information measures the level of 
charity care provided during the years ended December 31,19X7 and 19X6.
19X7 19X6
Charges foregone, based on established rates $6,000,000 $5,700,000
Estimated costs and expenses incurred to provide charity care 5,600,000 5,000,000
Equivalent percentage of charity care patients to all patients served 5.7% 5.6%
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3. Net Patient Service Revenue
The Hospital has agreements with third-party payors that provide for payments to the Hospital at amounts different 
from its established rates. A summary of the payment arrangements with major third-party payors follows.
• Medicare. Inpatient acute care services rendered to Medicare program beneficiaries are paid at prospectively 
determined rates per discharge. These rates vary according to a patient classification system that is based on 
clinical, diagnostic, and other factors. Inpatient nonacute services, certain outpatient services, and defined 
capital and medical education costs related to Medicare beneficiaries are paid based upon a cost reimburse­
ment methodology. The Hospital is reimbursed for cost reimbursable items at a tentative rate with final 
settlement determined after submission of annual cost reports by the Hospital and audits thereof by the 
Medicare fiscal intermediary. The Hospital's classification of patients under the Medicare program and the 
appropriateness of their admission are subject to an independent review by a peer review organization under 
contract with the Hospital. The Hospital's Medicare cost reports have been audited by the Medicare fiscal 
intermediary through December 31, 19X6.
• Medicaid. Inpatient and outpatient services rendered to Medicaid program beneficiaries are reimbursed 
under a cost reimbursement methodology. The Hospital is reimbursed at a tentative rate with final settlement 
determined after submission of annual cost reports by the Hospital and audits thereof by the Medicaid fiscal 
intermediary. The Hospital's Medicaid cost reports have been audited by the Medicaid fiscal intermediary 
through December 31, 19X6.
• Blue Cross. Inpatient services rendered to Blue Cross subscribers are reimbursed at prospectively deter­
mined rates per day of hospitalization. The prospectively determined per diem rates are not subject to 
retroactive adjustment.
The Hospital has also entered into payment agreements with certain commercial insurance carriers, health main­
tenance organizations, and preferred provider organizations. The basis for payment to the Hospital under these 
agreements includes prospectively determined rates per discharge, discounts from established charges, and 
prospectively determined daily rates.
4. Investment in Affiliated Company
In 19X2, the Hospital entered into an agreement with two unrelated hospitals to establish and operate an ambula­
tory care center, Affiliated Company (Center). In accordance with this agreement, each hospital invested $970,000 
for a 33⅓ percent equity interest in the common stock of the Center. The investment was made in installments 
during the years 19X5 through 19X7, and in May 19X7 the Center began operations. The investment is recorded on 
the equity method.
Summarized financial information from the unaudited financial statements of the Center follows.
December 31, 19X7 December 31, 19X6
Current assets 
Noncurrent assets 
Current liabilities 
Noncurrent liabilities 
Shareholders' equity
$1,779,000
4,052,000
1,566,000
1,514,000
2,751,000
$1,835,000
4,007,000
1,325,000
2,789,000
1,728,000
Year Ended
December 31, 19X7 December 31, 19X6
Revenue 
Net loss
$3,220,000
(111,000)
$2,899,000
(48,000)
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5. Assets Whose Use Is Limited
Assets whose use is limited that are required for obligations classified as current liabilities are reported in current 
assets. The composition of assets whose use is limited at December 31, 19X7 and 19X6, is set forth in the following 
table. Investments are stated at cost that approximates market.
19X7
By board for capital improvements
Cash and short-term investments $11,000,000
By agreements with third-party payors for funded depreciation 
Cash and short-term investments $ 8,503,000
U.S. Treasury obligations 316,000
Interest receivable 415,000
$ 9,234,000
Under malpractice funding arrangement—held by trustee 
Cash and short-term investments $ 1,058,000
U.S. Treasury obligations 1,949,000
$ 3,007,000
Under indenture agreement—held by trustee
Cash and short-term investments $ 592,000
U.S. Treasury obligations 11,024,000
Interest receivable 92,000
$11,708,000
6. Property and Equipment
A summary of property and equipment at December 31, 19X7 and 19X6, follows.
19X7
Land $ 3,000,000
Land improvements 472,000
Buildings and improvements 46,852,000
Equipment 29,190,000
Equipment under capital leases 2,851,000
82,365,000
Less accumulated depreciation and amortization 34,928,000
47,437,000
Construction in progress 3,601,000
Property and equipment, net $51,038,000
19X6
$10,000,000
$ 5,712,000 
316,000 
123,000
$ 6,151,000
$ 857,000
1,825,000
$ 2,682,000
$ 1,260,000 
9,674,000 
74,000
$11,008,000
19X6
$ 3,000,000 
472,000 
46,636,000 
26,260,000 
2,752,000
79,120,000
30,661,000
48,459,000
2,033,000
$50,492,000
Construction contracts of approximately $7,885,000 exist for the remodeling of Hospital facilities. At December 31, 
19X7, the remaining commitment on these contracts approximated $4,625,000.
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7. Long-Term Debt and Capital Leases
A summary of long-term debt and capital leases at December 31, 1987 and 19X6, follows.
19X7 19X6
9.25% Revenue Notes, due November 1, 19XX, collateralized by a pledge 
of the Hospital's gross receipts
9.25% mortgage loan, due January 19XX, collateralized by a mortgage 
on property and equipment with a depreciated cost of $1,800,000 at 
December 31, 19X7
9.75% note payable, due March 19XX, unsecured 
Total long-term debt
Less current instalments of long-term debt
Long-term debt excluding current installments
Capital lease obligations, at varying rates of imputed interest from 9.8% 
to 12.3%, on leased equipment with an amortized cost of $1,500,000 
at December 31, 19X7
Less current portion of capital lease obligations
Capital lease obligations, excluding current portion
$21,479,000
2,010,000
125,000
23,614,000
970,000
$22,644,000
$ 1,000,000 
500,000
$ 500,000
$22,016,000
2,127,000
671,000
24,814,000
1,200,000
$23,614,000
$ 950,000
550,000
$ 400,000
Under the terms of the Revenue Note Indenture, the Hospital is required to maintain certain deposits with a trustee. 
Such deposits are included with assets whose use is limited in the financial statements. The Revenue Note Inden­
ture also places limits on the incurrence of additional borrowings and requires that the Hospital satisfy certain 
measures of financial performance as long as the notes are outstanding.
Scheduled principal repayments on long-term debt and payments on capital lease obligations for the next five years 
are as follows:
Long-Term
Debt
Obligations 
Under Capital 
Leases
19X8 $ 970,000 $ 500,000
19X9 912,000 260,000
19Y0 983,000 260,000
19Y1 1,060,000 95,000
19Y2 1,143,000 —
$5,068,000 1,115,000
Less amount representing interest on
obligations under capital leases 115,000
$1,000,000
A summary of interest cost and investment income on borrowed funds held by the trustee under the Revenue Note
Indenture during 19X7 and 19X6 follows.
19X7 19X6
Interst cost
Capitalized $ 740,000 $ 740,000
Charged to operations 1,752,000 1,825,000
$2,492,000 $2,565,000
Investment income
Capitalized $ 505,000 $ 663,000
Credited to other revenue 330,000 386,000
$ 835,000 $1,049,000
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8. Medical Malpractice Claims
The Hospital is uninsured with respect to medical malpractice risks. Losses from asserted claims and from 
unasserted claims identified under the Hospital's incident reporting system are accrued based on estimates that 
incorporate the Hospital's past experience, as well as other considerations including the nature of each claim or 
incident and relevant trend factors. Accrued malpractice losses have been discounted at rates ranging from 7 percent 
to 9 percent. No accrual for possible losses attributable to incidents that may have occurred but that have not been 
identified under the incident reporting system has been made because the amount is not reasonably estimable. 
The Hospital has established an irrevocable trust fund for the payment of medical malpractice claim settlements. 
Professional insurance consultants have been retained to assist the Hospital with determining amounts to be 
deposited in the trust fund.
9. Endowment Funds—Investments
Donor-restricted endowment fund investment portfolios include marketable equity securities that are carried at 
the lower of cost or market. Marketable equity securities of endowment funds at December 31, 19X7 and 19X6, are 
summarized as follows:
Cost
Quoted
Market
Value
Gross
Unrealized
Gains
Gross
Unrealized
Losses
19X7 $1,476,000 $1,301,000 $ 8,000 $183,000
19X6 1,620,000 1,832,000 228,000 16,000
Realized gains on marketable equity securities of endowment funds amounted to $10,000 in 19X7 and $50,000 
in 19X6.
10. Assets Held in Trust
The Hospital is an income beneficiary of the Thomas A. Smith Trust. Because the assets of the trust are not 
controlled by the Hospital, they are not included in the Hospital's financial statements. At December 31, 19X7, the 
market value of the assets totaled approximately $2,652,000. Distributions of income are made at the discretion of 
the trustees. Income distributed to the Hospital by the trust is restricted for construction or equipment additions 
and amounted to $150,000 in 19X7 and $140,000 in 19X6.
11. Related Party Transactions
Because of the existence of common trustees and other factors, the Hospital and Sample Health Foundation (Foun­
dation) are related parties. The Foundation is authorized by the Hospital to solicit contributions on its behalf. In its 
general appeal for contributions to support the community's providers of health care services, the Foundation also 
solicits contributions for certain other health care institutions. In the absence of donor restrictions, the Foundation 
has discretionary control over the amounts, timing, and use of its distributions.
Contributions made by the Foundation to the Hospital during the years ended December 31, 19X7 and 19X6, are 
reported in the Hospital's financial statements as follows:
19X7 19X6
Unrestricted gifts and bequests
Restricted contributions for—
$375,000 $525,000
Specific purposes 300,000 200,000
Plant replacement and expansion 70,000 85,000
In addition, the Hospital made a capital contribution of $1,000,000 to Sample Health System during 19X6.
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12. Pension Plan
The Hospital has a defined benefit pension plan covering substantially all of its employees. The plan benefits are 
based on years of service and employee compensation during the last five years of covered employment. The Hospital 
makes annual contributions to the plan equal to the amounts of net periodic pension cost. Contributions are 
intended to provide not only for benefits attributed to service to date but also for those expected to be earned in the 
future.
The actuarially computed net periodic pension cost for 19X7 and 19X6 included the following components:
19X7 19X6
Service cost-benefits earned during the
period $905,000 $ 770,000
Interest cost on projected benefit obli­
gation 700,000 650,000
Actual return on plan assets (950,000) (800,000)
Net amortization and deferral 70,000 80,000
Net periodic pension cost $ 725,000 $ 700,000
Assumptions used in the accounting for net periodic pension cost were as follows:
As of December 31
19X7 19X6
Discount rates 7.0% 7.0%
Rates of increase in compensation levels 6.0 6.0
Expected long-term rate of return on assets 8.0 8.0
The following table sets forth the plan's funded status and amounts recognized in the Hospital's financial state­
ments at December 31, 19X7 and 19X6.
19X7
Actuarial present value of benefit obligations 
Vested benefit obligation 
Nonvested benefit obligation
Accumulated benefit obligation
Effect of projected future compensation levels
Projected benefit obligation
Plan assets at fair value (primarily listed stocks and U.S. bonds)
Plan assets in excess of projected benefit obligation
Unrecognized net gain from past experience different from that assumed 
Prior service cost not yet recognized in net periodic pension cost 
Unrecognized net asset at January 1, 19X6, being recognized over 15 years 
Prepaid pension cost, included in other assets in the balance sheet
19X6
$6,800,000
1,930,000
8,730,000
980,000
9,710,000
9,800,000
90,000
(40,000)
55,000
(70,000)
$ 35,000
$ 8,020,000 
1,900,000
9,920,000
1,000,000
10,920,000
11,050,000
130,000
(30,000)
50,000
(65,000)
$ 85,000
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13. Commitments
Leases that do not meet the criteria for capitalization are classified as operating leases with related rentals charged 
to operations as incurred.
The following is a schedule by year of future minimum lease payments under operating leases as of December 31, 
19X7, that have initial or remaining lease terms in excess of one year.
Year Ending Minimum Lease
December 31 Payments
19X8 $ 517,000
19X9 506,000
19Y0 459,000
19Y1 375,000
19Y2 343,000
Total minimum lease payments $2,200,000
Total rental expense in 19X7 and 19X6 for all operating leases was approximately $859,000 and $770,000, respectively.
14. Subsequent Event
On February 9, 19X8, the Hospital signed a contract in the amount of $1,050,000 for the purchase of certain real 
estate.
15. Concentrations of Credit Risk
The Hospital is located in Feeling, Illinois. The Hospital grants credit without collateral to its patients, most of whom 
are local residents and are insured under third-party payor agreements. Revenues from patients and third-party 
payors were as follows:
19X7 19X6
Medicare and Medicaid 20% 19%
Blue Cross 20 19
Other third-party payors 
(none over 10%) 27 26
Patients 33 36
100% 100%
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SAMPLE NURSING HOME, INC.
Statements of Income and Retained Earnings
Years Ended December 31, 19X2 and 19X1
19X2
Net patient service revenue $ 2,163,000
Other revenue 67,000
Total revenue 2,230,000
Expenses
Nursing services 1,083,000
Dietary services 228,000
General services 212,000
Administrative services 173,000
Interest 164,000
Provision for bad debts 92,000
Depreciation 69,000
Total expenses 2,021,000
Income from operations 209,000
Nonoperating gains—interest and dividends 18,000
Income before provision for income taxes 227,000
Provision for income taxes 80,000
Net income 147,000
Retained earnings at beginning of year 229,000
Retained earnings at end of year $ 376,000
19X1
$ 1,949,000 
22,000
1,971,000
1,010,000
225,000
212,000
147,000
172,000
83,000
57,000
1,906,000
65,000
7,000
72,000
29,000
43,000
186,000
$ 229,000
See accompanying notes to financial statements.
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SAMPLE NURSING HOME, INC.
Statements of Cash Flows
Years Ended December 31, 19X2 and 19X1
See accompanying notes to financial statements.
19X2 19X1
Cash flows from operating activities and gains
Cash received from residents and third-party payors $ 2,048,000 $ 1,796,000
Cash received from others 67,000 22,000
Cash paid to employees and suppliers (1,679,000) (1,495,000)
Interest and dividends received 10,000 10,000
Interest paid (160,000) (170,000)
Taxes paid (29,000) (30,000)
Deposits received from patients 35,000 15,000
Deposits refunded to patients (30,000) (20,000)
Net cash provided by operating activities and gains 262,000 128,000
Cash flows from investing activities
Purchase of land held for investment (20,000) —
Purchase of other investments (150,000) —
Proceeds from sale of property — 2,000
Additions to property and equipment (44,000) (79,000)
Cash invested in assets whose use is limited (23,000) —
Increase in notes receivable (9,000) —
Net cash used in investing activities (246,000) (77,000)
Cash flows from financing activities
Repayment of long-term debt (50,000) (50,000)
Net cash used by financing activities (50,000) (50,000)
Net increase (decrease) in cash (34,000) 1,000
Cash at beginning of year 129,000 128,000
Cash at end of year $ 95,000 $ 129,000
Reconciliation of Net income to Net Cash Provided by Operating Activities and Gains
Net income $147,000 $ 43,000
Adjustments to reconcile net income to net cash provided by 
operating activities and gains
Depreciation 69,000 57,000
Provision for bad debts 92,000 83,000
Amortization 6,000 6,000
Loss on disposal of property — 11,000
Increase (decrease) in deferred income tax liability (8,000) 7,000
Net effect of changes in receivables, supplies, prepaid expenses,
accounts payable, accrued expenses, and deposits (44,000) (79,000)
Net cash provided by operating activities and gains $262,000 $128,000
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SAMPLE NURSING HOME, INC.
Notes to Financial Statements
December 31, 19X2 and 19X1
1. Summary of Significant Accounting Policies
Sample Nursing Home, Inc. (Company) operates a 128-bed nursing home in Abacus, New State. A summary of the 
Company's significant accounting policies follows.
Income taxes
The provisions for income taxes are based on net income reported for financial reporting purposes. Deferred 
income taxes arise from temporary differences between financial and income tax reporting of various items (prin­
cipally depreciation). Tax credits are treated as a reduction of the provision for income taxes in the year in which the 
credits arise.
Patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from residents, third-party payors, and 
others for service rendered.
Revenue under third-party payor agreements is subject to audit and retroactive adjustment. Provisions for esti­
mated third-party payor settlements are provided in the period the related services are rendered. Differences 
between the estimated amounts accrued and interim and final settlements are reported in operations in the year of 
settlement.
Assets whose use is limited
Assets set aside by the board of directors for capital improvements and assets limited as to use under terms of a note 
indenture are classified as assets whose use is limited.
Property and equipment
Property and equipment are recorded at cost. Depreciation is calculated on the straight-line method over the 
estimated useful lives of depreciable assets.
Bond issuance costs
Costs incurred in issuing bonds are being amortized over the term of the bonds using the straight-line method. 
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months 
or less, excluding amounts whose use is limited by board designation or note indenture.
2. Assets Whose Use Is Limited
Assets whose use is limited under a note indenture agreement at December 31, 19X2 and 19X1, are summarized as 
follows:
19X2 19X1
U.S. Treasury obligations, at cost that approximates market $150,000 $130,000
Cash
Accrued interest income
23,000 21,000
3,000 2,000
$176,000 $153,000
Assets set aside by the board of directors for capital improvements consists of certificates of deposit, at a cost that 
approximates market.
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3. Long-Term Debt
Long-term debt at December 31, 19X2 and 19X1, was as follows:
19X2 19X1
9.5 percent notes payable to the City of Abacus, maturing $50,000 
annually through November 1, 19XX, with a final maturity of $1,000,000 
on November 1, 20XX
Less current maturities
$1,750,000 $1,800,000
50,000 50,000
$1,700,000 $1,750,000
The notes are collateralized by a first-mortgage lien on all property and equipment of the Company and a security 
interest in all of its receipts. The note indenture requires the maintenance of certain deposits with a trustee, which 
are included in assets whose use is limited.
Future maturities of long-term debt as of December 31, 19X2, follow.
19X3
19X4
19X5
19X6
19X7
Thereafter
5 50,000
50,000 
50,000 
50,000 
50,000
1,500,000
Total $1,750,000
4. Income Taxes
The provisions for income taxes on earnings were as follows:
19X2
Current
Federal $72,000
State 2,000
Total current 74,000
Deferred
Federal 6,000
State —
Total deferred 6,000
Total provision for income taxes $80,000
19X1
$15,000
15,000
13,000
1,000
14,000
$29,000
A reconciliation between the "statutory" federal income tax rate and the effective rate in the statements of income 
is as follows:
19X2 19X1
Statutory tax rate 34% 40%
State taxes, net of federal benefit 1 1
Effective tax rate 35% 41%
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample Hospital 
and therefore are not repeated here.]
6. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital 
and therefore are not repeated here.]
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Statements of Revenue and Expenses and Changes in Fund Deficit
Years Ended December 31, 19X5 and 19X4
See accompanying notes to financial statements.
19X5 19X4
Revenue
Resident fees earned including amortization of deferred revenue from
nonrefundable advance fees of $935,000 and $915,000 $ 3,946,000 $ 3,152,000
Patient revenue from nonresidents 249,000 275,000
Investment income 107,000 78,000
Other 75,000
4,377,000
68,000
3,573,000
Expenses
Resident care 649,000 566,000
Dietary 781,000 701,000
Health care 185,000 170,000
Plant 491,000 421,000
General and administrative 436,000 445,000
Depreciation 452,000 447,000
Interest 967,000
3,961,000
416,000
955,000
3,705,000
(132,000)
Decrease (increase) in obligation to provide future services and use of
facilities to current residents 12,000 (82,000)
Income (loss) from operations 428,000 (214,000)
Nonoperating gains—Contributions 109,000 73,000
Revenue and gains in excess of (less than) expenses 537,000 (141,000)
Fund deficit, beginning of year (1,489,000) (1,348,000)
Fund deficit, end of year $ (952,000) $(1,489,000)
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Cash flows from operating activities and nonoperating gains
Cash received from residents and third-party payors
Other receipts from operations
$ 3,252,000 
75,000
$ 2,341,000 
68,000
Investment income received 109,000 73,000
Contributions received 107,000 78,000
Cash paid to employees and suppliers (2,589,000) (2,042,000)
Interest paid (950,000) (945,000)
Net cash provided (used) by operating activities and nonoperating gains 4,000 (427,000)
Cash flows from investing activities
Acquisition of property and equipment (65,000) (250,000)
Cash invested in assets whose use is limited (412,000) (238,000)
Assets whose use is limited used for acquisition of property and equipment — 467,000
Net cash used by investing activities (477,000) (21,000)
Cash flows from financing activities
Proceeds from advance fees and deposits 615,000 857,000
Refunds of advance fees and deposits (46,000) (52,000)
Proceeds from issuance of long-term debt 26,000 —
Repayments of long-term debt (77,000) (307,000)
Net cash provided by financing activities 518,000 498,000
Net increase in cash 45,000 50,000
Cash at beginning of year 330,000 280,000
Cash at end of year $ 375,000 $ 330,000
Reconciliation of Revenue and Gains in Excess of (Less Than) Expenses
to Net Cash Provided (Used) by Operating Activities and Nonoperating Gains
Revenue and gains in excess of (less than) expenses $ 537,000 $ (141,000)
Adjustments to reconcile revenue and gains in excess of (less than) expenses
to net cash provided (used) by operating activities and nonoperating gains
Amortization of advance fees (935,000) (915,000)
Loss (gain) on obligation to provide future services (12,000) 82,000
Depreciation and amortization 459,000 475,000
Provision for bad debts 3,000 3,000
Net change in other assets and liabilities [details omitted for editorial
brevity*] (48,000) 69,000
Net cash provided (used) by operating activities and
nonoperating gains $ 4,000 $ (427,000)
*FASB Statement 95, Statement of Cash Flows, paragraph 29 [AC C25.127], requires that "The reconciliation of net 
income to net cash flow from operating activities.. .shall separately report all major classes of reconciling items".
See accompanying notes to financial statements.
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SAMPLE CONTINUING CARE RETIREMENT COMMUNITY
Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Continuing Care Retirement Community (CCRC) provides housing, health care, and other related services 
to residents through the operation of a retirement facility containing 249 apartments and a seventy-eight-bed health 
care facility. A summary of significant accounting policies follows.
Advance fees
Fees paid by a resident upon entering into a continuing care contract, net of the portion thereof that is refundable 
to the resident, are recorded as deferred revenue and are amortized to income using the straight-line method over 
the estimated remaining life expectancy of the resident.
Obligation to provide future services and use of facilities
CCRC annually calculates the present value of the net cost of future services and use of facilities to be provided to 
current residents and compares that amount with the balance of deferred revenue from advance fees. If the present 
value of the net cost of future services and use of facilities exceeds the deferred revenue from advance fees, a liability 
is recorded (obligation to provide future services and use of facilities to current residents) with the corresponding 
charge to income. The obligation is discounted at 9 percent, based on the expected long-term rate of return on 
government obligations.
Investments
Investments, which consist of U.S. Treasury obligations, are stated at cost, which approximates fair market value. 
Interest and investment income are recognized when earned.
2. Property and Equipment
Property and equipment are stated at cost. Donated property is recorded at its estimated fair value at date of receipt, 
which then is treated as cost. Depreciation is computed on the straight-line method based on the following 
estimated useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5-15 years
When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from 
the accounts, and any resulting gain or loss is recognized in income for the period. The cost of maintenance and 
repairs is expensed as incurred; significant renewals and betterments are capitalized.
3. Deferred Financing Costs
Deferred financing costs are being amortized using the interest method over the term of the related financing 
agreement.
4. Tax Status
CCRC is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is exempt 
from federal income taxes pursuant to Section 501(a) of the Internal Revenue Code.
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5. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5 19X4
10.75% mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33,000
8,961,000 9,012,000
Less current maturities 90,000 77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal and interest of $85,425 to May 20XX. 
The note is collateralized by a first mortgage on property and equipment with a depreciated value at December 31, 
19X5, of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, CCRC established an initial debt service reserve fund of $1,000,000 
at April 15, 19X3. All resident fees received thereafter, net of resident fee refunds and debt service payments not to 
exceed $300,000 annually in the first four years and $200,000 annually thereafter, are to be added to the debt service 
reserve fund until the total sum of $2,050,000 is accumulated. Since June 1, 19X4, CCRC is required to deliver to the 
Trustee $5,500 per month to establish maintenance reserves until the aggregate of such payments equals a residen­
tial unit reserve and a health care center reserve of $240,000 and $90,000, respectively. At December 31, 19X5, the 
trustee held investments aggregating $2,130,000. Such amount has been classified as assets whose use is limited. 
Scheduled annual principal maturities of long-term debt for the next five years are as follows:
19X6 $ 90,000
19X7 90,000
19X8 95,000
19X9 105,000
19Y0 105,000
6. Assets Whose Use Is Limited
[The disclosures contained in this note would be similar to the disclosures contained in Note 5 of Sample Hospital 
and therefore are not repeated here.]
7. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in Note 12 of Sample Hospital 
and therefore are not repeated here.]
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in Note 15 of Sample Hospital 
and therefore are not repeated here.]
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SAMPLE HOME HEALTH AGENCY
Statements of Revenue and Expenses and Changes in Fund Balance
Years Ended December 31, 19X5 and 19X4
19X5 19X4
Net patient service revenue (note 2) $ 4,042,000 $ 2,687,000
Other revenue 27,000 32,000
Total revenue 4,069,000 2,719,000
Expenses (note 5)
Professional care of patients 2,714,000 1,835,000
General and administrative 1,042,000 675,000
Occupancy 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Income from operations 140,000 71,000
Nonoperating gains
Contributions 19,000 15,000
Investment income 18,000 12,000
Total nonoperating gains 37,000 27,000
Revenue and gains in excess of expenses 177,000 98,000
Fund balance at beginning of year 252,000 154,000
Fund balance at end of year $ 429,000 $ 252,000
See accompanying notes to financial statements.
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SAMPLE HOME HEALTH AGENCY
Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
See accompanying notes to financial statements.
19X5 19X4
Cash flows from operating activities and nonoperating gains
Cash received from customers and third-party payors $ 3,721,000 $ 2,542,000
Other receipts from operations 22,000 32,000
Cash paid to employees and suppliers (3,683,000) (2,540,000)
Interest paid (11,000) (14,000)
Nonoperating gains 37,000 27,000
Net cash provided by operating activities and nonoperating gains 86,000 47,000
Cash flows from investing activities
Purchase of equipment (30,000) (19,000)
Purchase of investments (10,000) (15,000)
Net cash used by investing activities (40,000) (34,000)
Cash flows from financing activities
Payment of long-term debt
Net cash used by financing activities
(13,000) —
(13,000) —
Net increase in cash and cash equivalents 33,000 13,000
Cash and cash equivalents at beginning of year 41,000 28,000
Cash and cash equivalents at end of year $ 74,000 $ 41,000
Reconciliation of Revenue and Gains in Excess of Expenses to Net Cash Provided 
by Operating Activities and Nonoperating Gains
Revenue and gains in excess of expenses $ 177,000 $ 98,000
Adjustments to reconcile revenue and gains in excess of expenses 
to net cash provided by operating activities and nonoperating gains
Provision for bad debts 46,000 21,000
Depreciation and amortization 26,000 20,000
Increase in accounts receivable (322,000) (150,000)
Increase in other receivables (5,000) (2,000)
Increase in accounts payable and accrued expenses 163,000 50,000
Decrease (increase) in estimated third-party receivables (3,000) 3,000
Increase in advances from third-party payors 4,000 7,000
Net cash provided by operating activities and nonoperating gains $ 86,000 $ 47,000
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SAMPLE HOME HEALTH AGENCY
Notes to Financial Statements
Years Ended December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Sample Home Health Agency (the Agency) was incorporated in 19X0 as a not-for-profit corporation. The Agency 
provides health and supportive services to individuals at their homes.
Charity care
The Agency has a policy of providing charity care to patients who are unable to pay. Such patients are identified 
based on financial information obtained from the patient and subsequent analysis. Since the Agency does not expect 
payment, estimated charges for charity care are not included in revenue.
Net patient service revenue
Net patient service revenue represents the estimated net realizable amounts from patients, third-party payors, and 
others for services rendered.
Income taxes
The Agency is a not-for-profit corporation as described in Section 501(c)(3) of the Internal Revenue Code and is 
exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
Assets whose use is limited
Assets set aside for board-designated purposes are classified as assets whose use is limited.
Investments
Investments consist of U.S. Treasury obligations at cost, which approximates market value.
Equipment
Equipment is recorded at cost. Depreciation is computed using the straight-line method over the estimated useful 
lives of the assets.
Cash and cash equivalents
Cash and cash equivalents include investments in highly liquid debt instruments with a maturity of three months 
or less, excluding amounts whose use is limited by board designation.
2. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 19X5 and 37 percent in 19X4 of net patient service revenue was derived under federal 
and state third-party reimbursement programs. These revenues are based, in part, on cost reimbursement prin­
ciples and are subject to audit and retroactive adjustment by the respective third-party fiscal intermediaries. In the 
opinion of management, retroactive adjustments, if any, would not be material to the financial position, results of 
operations or cash flows of the Agency.
3. Board-Designated Assets
The board of directors has designated cash and investments aggregating $135,000 to be used for future major capital 
improvements. Those assets are classified in the balance sheets as assets whose use is limited.
114
4. Long-Term Debt
Long-term debt at December 31, 19X5 and 19X4, is as follows:
19X5 19X4
Note payable to bank, interest at 15%, collateralized by equipment 
with a depreciated cost in 19X5 of $42,000
Less current maturities
Long-term debt, less current maturities
Scheduled maturities of long-term debt at December 31, 19X5 are as follows
$118,000 $131,000
13,000 13,000
$105,000 $118,000
19X6 $ 13,000
19X7 13,000
19X8 13,000
19X9 13,000
19X0 13,000
Thereafter 53,000
Total $118,000
5. Pension Plan
[The disclosures contained in this note would be similar to the disclosures contained in note 12 of Sample 
Hospital.]
6. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in 19X5 and 19X4, respectively.
7. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample 
Hospital.]
115
SA
M
PL
E 
HE
AL
TH
 M
AI
NT
EN
AN
CE
 O
RG
AN
IZ
AT
IO
N
Ba
la
nc
e 
Sh
ee
ts
De
ce
m
be
r 3
1,
 19
X5
 a
nd
 19
X4
__
__
__
Li
ab
ili
tie
s a
nd
 F
un
d 
Ba
la
nc
e_
__
__
_
 
19
X5
 
19
X4
Cu
rr
en
t l
ia
bi
lit
ie
s
U
ns
ec
ur
ed
 12
%
 no
te
 p
ay
ab
le
 to
 a 
ba
nk
 
$ 
—
 
$ 
44
,0
00
Po
rti
on
 o
f l
on
g-
te
rm
 d
eb
t p
ay
ab
le
w
ith
in
 o
ne
 y
ea
r (
no
te
 4)
 
24
1,
00
0 
10
9,
00
0
A
cc
ou
nt
s p
ay
ab
le
—
m
ed
ica
l
se
rv
ice
s 
2,
24
5,
00
0 
1,
47
1,
00
0
O
th
er
 ac
co
un
ts
 p
ay
ab
le
 an
d
ac
cr
ue
d 
ex
pe
ns
es
 
82
9,
00
0 
66
1,
00
0
U
ne
ar
ne
d 
pr
em
iu
m
 re
ve
nu
e 
14
1,
00
0 
20
2,
00
0
To
ta
l c
ur
re
nt
 li
ab
ili
tie
s 
3,
45
6,
00
0 
2,
48
7,
00
0
Lo
ng
-te
rm
 d
eb
t, l
es
s p
or
tio
n 
pa
ya
bl
e 
w
ith
in
 o
ne
 y
ea
r (
no
te
 4)
 
4,
29
5,
00
0 
4,
38
2,
00
0
Co
m
m
itm
en
ts 
an
d 
co
nt
in
ge
nc
ie
s 
(n
ot
es
 2 
an
d 
8)
Fu
nd
 b
al
an
ce
 
2,
11
8,
00
0 
90
0,
00
0
To
ta
l l
ia
bi
lit
ie
s a
nd
 fu
nd
ba
la
nc
e 
$9
,8
69
,0
00
 
$7
,7
69
,0
00
__
__
__
__
__
__
__
__
_A
ss
et
s_
__
__
__
__
__
__
__
__
 19X5 
19
X4
Cu
rr
en
t a
ss
et
s
Ca
sh
 
$ 
2,
00
0 
$ 193,0
00
Te
m
po
ra
ry
 ca
sh
 in
ve
st
m
en
ts
 
2,
93
5,
00
0 
82
8,
00
0
Pr
em
iu
m
s r
ec
ei
va
bl
e 
35
8,
00
0 
40
7,
00
0
O
th
er
 re
ce
iv
ab
le
s 
26
3,
00
0 
26
1,
00
0
Su
pp
lie
s 
19
0,
00
0 
18
4,
00
0
Pr
ep
ai
d 
ex
pe
ns
es
 
19
7,
00
0 
99
,0
00
To
ta
l c
ur
re
nt
 as
se
ts
 
3,
94
5,
00
0 
1,
97
2,
00
0
Pr
op
er
ty
 an
d 
eq
ui
pm
en
t (
no
te
s 3
 an
d 
4)
 
7,
55
9,
00
0 
7,
06
2,
00
0
Le
ss
 ac
cu
m
ul
at
ed
 d
ep
re
cia
tio
n a
nd
am
or
tiz
at
io
n 
1,
80
3,
00
0 
1,
43
6,
00
0
5,
75
6,
00
0 
5,
62
6,
00
0
St
at
e g
ua
ra
nt
y 
fu
nd
 d
ep
os
it 
(n
ot
e 5
) 
15
0,
00
0 
15
0,
00
0
D
eb
t i
ss
ua
nc
e c
os
ts
, n
et
 o
f a
cc
um
ul
at
ed
 
am
or
tiz
at
io
n 
of
 $4
2,
00
0 i
n 
19
X5
 an
d
$3
9,
00
0 i
n 
19
X4
 
18
,0
00
 
21
,0
00
To
ta
l a
ss
et
s 
$ 9
,8
69
,0
00
 
$ 7
,7
69
,0
00
Se
e a
cc
om
pa
ny
in
g 
no
te
s t
o f
in
an
ci
al
 st
at
em
en
ts
.
116
SAMPLE HEALTH MAINTENANCE ORGANIZATION
Statements of Revenue and Expenses 
and Changes in Fund Balance 
Years Ended June 30, 19X5 and 19X4
19X5
Revenue
Premiums earned $27,682,000
Coinsurance 689,000
Interest and other income 242,000
28,613,000
Expenses
Contracted hospital, physician, and other services 12,749,000
Health centers—medical services 10,116,000
Health centers—administration 1,556,000
General administration 1,695,000
Membership services 527,000
Interest 385,000
Depreciation and amortization 367,000
27,395,000
Income from operations 1,218,000
Fund balance at beginning of year 900,000
Fund balance at end of year $ 2,118,000
19X4
$22,500,000
500,000
100,000
23,100,000
9,734,000
8,786,000
1,530,000
1,309,000
440,000
375,000
336,000
22,510,000
590,000
310,000
$ 900,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
Statements of Cash Flows
Years Ended June 30, 19X5 and 19X4
19X5 19X4
Cash flows from operating activities
Cash received from premiums, stop-loss insurance recoveries, 
and coinsurance $ 28,969,000 $ 24,410,000
Cash paid to employees and to providers of health care services (26,405,000) (22,818,000)
Interest received 230,000 90,000
Interest paid (382,000) (372,000)
Net cash provided by operating activities 2,412,000 1,310,000
Cash flows from investing activities
Additions to property and equipment (497,000) (121,000)
Net cash used by investing activities (497,000) (121,000)
Cash flows from financing activities
Proceeds from long-term debt 300,000
Repayment of long-term debt (299,000) (1,000,000)
Net cash provided (used) by financing activities 1,000 (1,000,000)
Net increase in cash and temporary cash investments 1,916,000 189,000
Beginning cash and temporary cash investments 1,021,000 832,000
Ending cash and temporary cash investments $ 2,937,000 $ 1,021,000
Reconciliation of Income From Operations to Net Cash Provided 
by Operating Activities
Income from operations $ 1,218,000 $ 590,000
Adjustments to reconcile income from operations to net cash provided 
by operating activities
Depreciation and amortization 370,000 339,000
Increase in accounts payable—medical services 774,000 335,000
Increase (decrease) in unearned premium revenue (61,000) 115,000
Decrease in premiums receivable 49,000 84,000
Net effect of changes in other receivables, supplies, prepaid expenses, 
and other payables 62,000 (153,000)
Net cash provided by operating activities $ 2,412,000 $ 1,310,000
See accompanying notes to financial statements.
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SAMPLE HEALTH MAINTENANCE ORGANIZATION
Notes to Financial Statements
June 30, 19X5 and 19X4
1. Formation and Purpose
Sample Health Maintenance Organization (Sample HMO) was incorporated in 19X0 as a not-for-profit corporation 
for the purpose of providing comprehensive health care services on a prepaid basis and for the purpose of establish­
ing and operating organized health maintenance and health care delivery systems.
Sample HMO has been determined to be a qualified health maintenance organization (HMO) under Title XIII of the 
Public Health Service Act.
2. Summary of Significant Accounting Policies
Temporary cash investments
Temporary cash investments at June 30, 19X5 and 19X4, include a repurchase agreement with a bank and certificates 
of deposit with original maturities of less than ninety days carried at a cost that is equivalent to market.
Premiums revenue
Membership contracts are on a yearly basis subject to cancellation by the employer group or Sample HMO upon 
thirty days written notice. Premiums are due monthly and are recognized as revenue during the period in which 
Sample HMO is obligated to provide services to members.
Health care service cost recognition
Sample HMO contracts with various health care providers for the provision of certain medical care services to its 
members. Sample HMO compensates those providers on a capitation basis. As part of a cost control incentive 
program, Sample HMO retains up to XX percent of the capitation as a risk-sharing fund. In the event of hospital 
utilization in excess of budget, those providers bear the risk to the extent of XX percent of the capitation fee. 
Operating expenses include all amounts incurred by Sample HMO under the aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in the period in which it is provided 
to a member based in part on estimates, including an accrual for medical services provided but not reported to 
Sample HMO.
Inventories of supplies
Inventories of drugs and other supplies are stated at the lower of cost (first-in, first-out) or market.
Property and equipment
Property and equipment are recorded at cost, less accumulated depreciation. Maintenance and repairs are charged 
to expense, and betterments are capitalized. Property and equipment costing approximately $700,000 was financed 
by initial development grants received in 19X1 and 19X2 from the U.S. Department of Health and Human Services. 
This property will be owned by Sample HMO as long as the equipment and facilities are used for projects related 
to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated useful lives of the related assets as 
follows:
Building 40 years
Improvements 20-25 years
Data processing and laboratory equipment and automobiles 3-7 years
Medical equipment 10 years
Office equipment 5-10 years
Amortization of debt issuance costs
Debt issuance costs are deferred and amortized using the interest method over the term of the related debt.
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Retirement plan expense
Sample HMO has a retirement plan as more fully described in note 6. Charges to expense are recognized when 
Sample HMO makes contributions to the plan.
Federal income tax
Sample HMO is exempt from federal income taxes under Section 501(c)(4) of the Internal Revenue Code; accord­
ingly, no provision for federal income taxes has been made in the accompanying financial statements. 
Reinsurance (stop-loss insurance)
Reinsurance premiums are reported as health care costs, and reinsurance recoveries are reported as revenue.
3. Property and Equipment
Property and equipment at June 30, 19X5 and 19X4, consists of the following:
19X5 19X4
Land $ 300,000 $ 300,000
Buildings and improvements 5,473,000 5,459,000
Furniture and equipment 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation 1,803,000 1,436,000
$ 5,756,000 $ 5,626,000
4. Long-Term Debt
Long-term debt is collateralized by assets with a depreciated cost at June 30, 19X5 of $4,943,000. A summary of long­
term debt at June 30, 19X5 and 19X4, follows.
$ 4,295,000 $ 4,382,000
19X5 19X4
HHS loan, interest at 7.5%
HHS loan, interest at 9.25%
Secured equipment loans
$ 2,020,000 
1,658,000 
858,000
$ 2,111,000 
1,694,000 
686,000
4,536,000 4,491,000
Less portion payable within one year 241,000 109,000
Scheduled principal payments on long-term debt are as follows:
Scheduled Principal
Fiscal Year Payments
19X6 $ 241,000
19X7 259,000
19X8 280,000
19X9 800,000
19Y0 2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 19X5 the state in which Sample HMO is domiciled enacted legislation specifically governing HMOs. 
Under this legislation, Sample HMO is required to maintain a deposit of $150,000 with the director of the division 
of insurance of the state.
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6. Employee Retirement Plan
Sample HMO has a contributory defined contribution retirement plan covering substantially all employees. 
Expense determined in accordance with the plan formula (4 percent to 10 percent of eligible covered compensation) 
was $354,000 for the year ended June 30, 19X5 ($275,000 for 19X4).
7. Stop-loss Insurance
Sample HMO has entered into a stop-loss insurance agreement with an insurance company to limit its losses 
on individual claims. Under the terms of this agreement, the insurance company will reimburse Sample HMO 
approximately XX percent of the cost of each member's annual hospital services, in excess of a $XXX deductible, 
up to a lifetime limitation of $XXX per member. In the event Sample HMO ceases operations, (a) plan benefits will 
continue for members who are confined in an acute care hospital on the date of insolvency until their discharge and 
(b) plan benefits will continue for any other member until the end of the contract period for which premiums have 
been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are included in health care costs in 19X5 and 
19X4, respectively. Approximately $600,000 and $400,000 of stop-loss insurance recoveries are deducted from health 
care costs in 19X5 and 19X4, respectively.
Included in other receivables is approximately $50,000 recoverable from insurers.
8. Malpractice Claims
Malpractice claims have been asserted against Sample HMO by various claimants. The claims are in various stages 
of processing, and some may ultimately be brought to trial. In the opinion of counsel, the outcome of these actions 
will not have a significant effect on the financial position, results of operations or cash flows of Sample HMO. 
Incidents occurring through June 30, 19X5, may result in the assertion of additional claims. Other claims may be 
asserted arising from past services provided. Management believes that these claims, if asserted, would be settled 
within the limits of insurance coverage.
9. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital.]
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SAMPLE AMBULATORY CARE, INC.
Statements of Revenue and Expenses 
and Changes in Fund Balance 
Years Ended December 31, 19X5 and 19X4
Net patient service revenue (note 7)
Operating gains
Total operating revenue and gains 
Expenses
Salaries and wages 
Employee benefits 
Supplies
Purchased services 
Insurance 
Professional fees 
Interest 
Depreciation
Total expenses 
Loss from operations
Nonoperating gain—interest income
Expenses in excess of revenue and gains
Fund balance at beginning of period 
Fund balance at end of period
19X5
$ 860,000 
26,000
886,000
425,000
77,000
107,000
177,000
34,000
27,000
15,000
117,000
979,000
(93,000)
3,000
(90,000)
2,541,000
$2,451,000
19X4
$ 357,000 
14,000
371,000
184,000
54,000
52,000
109,000
22,000
1,000
17,000
100,000
539,000
(168,000)
11,000
(157,000)
2,698,000
$2,541,000
See accompanying notes to financial statements.
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SAMPLE AMBULATORY CARE, INC.
Statements of Cash Flows
Years Ended December 31, 19X5 and 19X4
See accompanying notes to financial statements.
19X5 19X4
Cash flows from operating activities and gains
Cash received from patients and third-party payors $ 866,000 $ 368,000
Cash received from others 21,000 6,000
Interest received 3,000 11,000
Interest paid (15,000) (16,000)
Cash paid to employees and suppliers (870,000) (432,000)
Net cash provided from (used for) operating activities and gains 5,000 (63,000)
Cash flows from investing activities
Purchase of equipment (1,000) (4,000)
Advances made (9,000) (5,000)
Net cash used for investing activities (10,000) (9,000)
Cash flows from financing activities
Proceeds from notes payable — 144,000
Payments on notes payable (6,000) —
Net cash provided from (used for) financing activities (6,000) 144,000
Net increase (decrease) in cash (11,000) 72,000
Cash at beginning of year 76,000 4,000
Cash at end of year $ 65,000 $ 76,000
Reconciliation of Expenses in Excess of Revenues and Gains to Net Cash Provided
From (Used For) Operating Activities and Gains
Net loss $ (90,000) $(157,000)
Adjustments to reconcile expenses in excess of revenues and gains to 
net cash provided from (used for) operating activities and gains
Depreciation 117,000 100,000
Provision for bad debts 14,000 4,000
Net increase in receivables and net third-party payor adjustments (12,000) (19,000)
Net decrease (increase) in inventories of supplies, prepaid expenses and deposits 1,000 (2,000)
Net increase (decrease) in accounts payable, accrued expenses and advances
from Blue Cross (25,000) 11,000
Net cash provided from (used for) operating activities and gains $ 5,000 $ (63,000)
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SAMPLE AMBULATORY CARE, INC.
Notes to Financial Statements
December 31, 19X5 and 19X4
1. Summary of Significant Accounting Policies
Net patient service revenue
Patient service revenue is reported at the estimated net realizable amounts from patients, third-party payors, and 
others for services rendered.
Third-party contractual adjustments
Retroactively calculated third-party contractual adjustments are accrued on an estimated basis in the period the 
related services are rendered. Net patient service revenue is adjusted as required in subsequent periods based on 
final settlements.
Charity care
Sample Ambulatory Care, Inc. has a policy of providing charity care to patients who are unable to pay. Such patients 
are identified and related charges are estimated, based on financial information obtained from the patient and 
subsequent analysis. Since management does not expect payment for charity care, the estimated charges are 
excluded from revenue.
Supplies
Supplies are stated at the lower of cost (first-in, first-out) or net realizable value.
Depreciation
Depreciation of property and equipment is computed on the straight-line method over the estimated lives of 
depreciable assets.
Investment income
Investment income and gains on investment transactions are recorded as nonoperating revenue.
2. Formation and Scope of Operations
Sample Ambulatory Care, Inc. was incorporated on September 7, 19X3, to operate an ambulatory care health facility 
to treat or prevent injury and disease, to provide funds or to expend funds to further the treatment or prevention 
of injury or disease, and to develop and participate in activities designed to promote the general health of the 
community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and GHI Hospital—entered into a members' 
agreement to develop this ambulatory care center. In accordance with this agreement, each hospital contributed 
capital of $947,000 to Sample Ambulatory Care, Inc.
Sample Ambulatory Care, Inc. began operations in October 19X3.
3. Related Party Transactions
During 19X3, Sample Ambulatory Care, Inc. entered into a contract with one of the member hospitals (managing 
hospital) for the management of the business and affairs of Sample Ambulatory Care, Inc. Under this agreement, 
Sample Ambulatory Care, Inc. pays $4,000 per month to the managing hospital. The agreement with the managing 
hospital was to remain in effect through December 31, 19X5, but has been extended on a month-to-month basis.
In addition, during 19X4, each hospital loaned $48,000 to Sample Ambulatory Care, Inc. in the form of promissory 
notes at an interest rate of prime plus one percent (effective rates of 10 percent and 9 percent in 19X5 and 19X4, 
respectively). Of the total $144,000 liability, $48,000 is payable on demand after November 28, 19X5, to one member 
hospital, with the remaining portion ($96,000) payable on demand after December 8, 19X5, to the other two member 
hospitals. During 19X5, Sample Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing the 
obligation to $138,000.
125
4. Revenue From Contracting Agencies
Sample Ambulatory Care, Inc. participates as a provider of health care services to Blue Cross, Medicare, and 
County Indigent Plan patients. Reimbursement for covered services is based on tentative payment rates. Final 
reimbursement rates are determined after submission of annual cost reports and audits thereof by the fiscal inter­
mediaries. Provisions for estimated reimbursement adjustments are reported in the financial statements in the 
period that the services are rendered.
5. Advances Receivable
In May 19X4 Sample Ambulatory Care, Inc. entered into a five-year agreement with XYZ Affiliates (XYZ). Under 
this agreement, XYZ is to provide emergency medical services as well as charge and bill each patient treated at 
Sample Ambulatory Care, Inc. Sample Ambulatory Care, Inc. has guaranteed that XYZ will collect at least $18,000 
per month during the term of this agreement. In any month in which XYZ does not collect the minimum guarantee, 
Sample Ambulatory Care, Inc. advances funds to XYZ to cover the deficiency. Such advances are to be repaid to the 
extent XYZ's net cash collections exceed the minimum guarantee amount. Management estimates that the advances 
will be fully recovered in 19X6.
6. Income Taxes
Sample Ambulatory Care, Inc. is a not-for-profit corporation as described in Section 501(c)(3) of the Internal 
Revenue Code and is exempt from federal income taxes on related income pursuant to Section 501(a) of the Code.
7. Charity Care
Sample Ambulatory Care, Inc. has a policy of providing charity care to indigent patients in emergency situations. 
These services, which are excluded from revenues, amounted to $27,000 and $13,000 in 19X3 and 19X4, respectively, 
when measured at Sample Ambulatory Care, Inc.'s established rates.
8. Concentrations of Credit Risk
[The disclosures contained in this note would be similar to the disclosures contained in note 15 of Sample Hospital.]
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[Date]
UNQUALIFIED OPINION—COMPARATIVE 
FINANCIAL STATEMENTS
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Entity
We have audited the accompanying balance sheets of XYZ Health Care Entity as of September 30, 19X2 and 19X1, 
and the related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of 
general funds for the years then ended. These financial statements are the responsibility of XYZ Health Care 
Entity's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those standards require that 
we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of 
material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and 
disclosures in the financial statements. An audit also includes assessing the accounting principles used and signifi­
cant estimates made by management, as well as evaluating the overall financial statement presentation. We believe 
that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial posi­
tion of XYZ Health Care Entity as of September 30, 19X2 and 19X1, and the results of its operations and its cash flows 
of general funds for the years then ended in conformity with generally accepted accounting principles.
[Signature]
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[Date]
To the Board of Trustees
XYZ Health Care Entity
UNQUALIFIED OPINION WITH EXPLANATORY PARAGRAPH — 
MATERIAL UNCERTAINTY
Independent Auditor's Report
[Standard wording for first three paragraphs]
As more fully described in note X, claims in excess of professional liability insurance coverage have been asserted 
against XYZ Health Care Entity. Legal counsel and management are unable to estimate the ultimate cost, if any, that 
may result from the resolution of those claims; accordingly, no provision for claims in excess of professional liability 
insurance has been made in the accompanying financial statements.
[Signature]
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[Date]
To the Board of Trustees
XYZ Health Care Entity
QUALIFIED OPINION—SCOPE LIMITATION
Independent Auditor's Report
[Same first paragraph as the standard report]
Except as discussed in the following paragraph, we conducted our audits in accordance with generally accepted 
auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance 
about whether the financial statements are free of material misstatement. An audit includes examining, on a test 
basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes 
assessing the accounting principles used and significant estimates made by management, as well as evaluating the 
overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
We were unable to obtain audited financial statements supporting XYZ Health Care Entity's investment in an
affiliate stated at $____________ and $_____________at September 30,19X2 and 19X1, respectively, or its equity in the
earnings of that affiliate of $____________ and $_____________ , which amounts are included in the excess of
revenues and gains over expenses for the years then ended as described in Note X to the financial statements; nor 
were we able to satisfy ourselves as to the carrying value of the investment in the affiliate or the equity in its earnings 
by other auditing procedures.
In our opinion, except for the effects of such adjustments, if any, as might have been determined to be necessary 
had we been able to obtain adequate evidence regarding the affiliate investment and earnings, the financial statements 
referred to in the first paragraph present fairly, in all material respects, the financial position of XYZ Health Care 
Entity as of September 30, 19X2 and 19X1, and the results of its operations and its cash flows of general funds for 
the years then ended in conformity with generally accepted accounting principles.
[Signature]
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[Date]
STANDARD REVIEW REPORT ON FINANCIAL 
STATEMENTS—NONPUBLIC ENTITY
To the Board of Trustees
XYZ Health Care Entity
We have reviewed the accompanying balance sheet of XYZ Health Care Entity as of December 31, 19XX, and the 
related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of general 
funds for the year then ended, in accordance with Statements on Standards for Accounting and Review Services 
issued by the American Institute of Certified Public Accountants. All information included in these financial state­
ments is the representation of the management of XYZ Health Care Entity.
A review consists principally of inquiries of entity personnel and analytical procedures applied to financial data. It 
is substantially less in scope than an audit in accordance with generally accepted auditing standards, the objective 
of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do 
not express such an opinion.
Based on our review, we are not aware of any material modifications that should be made to the accompanying 
financial statements in order for them to be in conformity with generally accepted accounting principles.
[Signature]
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[Date]
STANDARD COMPILATION REPORT ON FINANCIAL 
STATEMENTS—NONPUBLIC ENTITY
To the Board of Trustees
XYZ Health Care Entity
We have compiled the accompanying balance sheet of XYZ Health Care Entity as of December 31, 19XX, and the 
related statements of revenue and expenses of general funds, changes in fund balances, and cash flows of general 
funds for the year then ended, in accordance with Statements on Standards for Accounting and Review Services 
issued by the American Institute of Certified Public Accountants.
A compilation is limited to presenting in the form of financial statements information that is the representation of 
management. We have not audited or reviewed the accompanying financial statements and, accordingly, do not 
express an opinion or any other form of assurance on them.
[Signature]
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TECHNICAL HOTLINE
The AICPA Technical Information Service answers 
inquiries about specific audit or accounting problems. 
Call Toll Free 
(800) TO-AICPA
This service is free to AICPA members.
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